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Resumo 
Os oligodendrócitos (OL) são as células mielinizantes do sistema nervoso central 
(SNC). A Esclerose Múltipla (EM) é a doença desmielinizante mais frequente do SNC 
e pensa-se que a sua progressão é devida à incapacidade das células precursoras de 
oligodendrócitos (OPC) se diferenciarem em novas células mielinizantes no 
microambiente inibidor das lesões da EM. Durante a diferenciação, uma OPC é 
inicialmente bipolar e estende os seus processos para depois ramificar (OL imaturo) e 
finalmente produzir uma membrana de mielina. Este OL maduro pode, assim, 
contactar com um axónio para o mielinizar. 
Globalmente, o objetivo deste projeto é identificar e estudar o papel de novas 
moléculas que tenham um papel importante da diferenciação de OL e mielinização. 
Para tal, estabeleceu-se previamente uma técnica para separar fisicamente o soma 
dos processos das OPC e sequenciaram-se os mRNAs das duas frações. 
Hipotetizámos que os mRNAs enriquecidos nos processos teriam uma maior 
probabilidade de ter um papel relevante na diferenciação e mielinização de OL. Vários 
mRNAs foram identificados como estando significativamente enriquecidos nos 
processos das OPC e, destes, foram selecionados quatro candidatos com base no seu 
envolvimento na modulação do citoesqueleto e regulação da tradução proteica: Kank2, 
Dusp19, PABPC1 e YBX1. 
Em particular, o objetivo principal desta tese de Mestrado é estudar o papel funcional 
de Kank2, Dusp19, PABPC1 e YBX1 na diferenciação de OL, nomeadamente a nível 
da extensão e ramificação dos processos bem como da produção de mielina. Neste 
contexto, pretendemos também desenvolver um protocolo de análise automática da 
morfologia de OL. Os nossos resultados mostram que os OL onde foi feita a depleção 
do mRNA de Kank2, Dusp19, PABPC1 e YBX1 sofreram um atraso na diferenciação 
quando comparados com o controlo. Este atraso caracteriza-se por um enriquecimento 
da população de células em estadios de diferenciação mais precoces (análise manual 
por categorização). Também se verifica uma redução da percentagem de células com 
marcação positiva para a MBP (myelin basic protein, proteína básica da mielina) após 
depleção do mRNA de Kank2, Dusp19 e PABPC1. No caso da depleção de YBX1 
verifica-se um aumento não significativo da percentagem de células com marcação 
positiva para MBP. Deste modo, pudemos concluir que os candidatos identificados por 
sequenciação de RNA têm, de facto, um papel relevante na diferenciação dos OL. 
Palavras-chave 
Oligodendrócito, mielina, citosqueleto, proteínas de ligação ao RNA, diferenciação 
morfológica, análise de imagem de elevado rendimento. 
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Abstract 
The oligodendrocyte (OL) is the myelinating cell in the central nervous system (CNS). 
Multiple Sclerosis (MS) is the most frequent demyelinating disease in the CNS and it is 
thought that its progression is due to oligodendrocyte progenitor cells’ (OPC) inability to 
differentiate into new myelinating cells in the inhibitory microenvironment of MS lesions. 
During differentiation, an OPC is initially bipolar and extends its processes, which 
become ramified (immature OL) and finally produce a myelin membrane. This mature 
OL can contact an axon and myelinate it. 
Globally, the aim of this project is to identify and study novel molecules, which may 
have an important role in OL differentiation and myelination. To do so, a technique was 
established to physically separate OPC soma from processes and mRNA from these 
two fractions was sequenced. It was hypothesized that mRNAs enriched in the 
processes would have a higher probability of having an important role in OL process 
extension, branching and myelination. Several mRNAs were identified to be 
significantly enriched in OPC process and, of these, four candidates were selected 
based on their role in cytoskeleton modulation and regulation of protein translation: 
Kank2, Dusp19, PABPC1 and YBX1. 
In particular, the main purpose of this Master thesis is to study the functional role of 
Kank2, Dusp19, PABPC1 and YBX1 in OL differentiation, with special regard to 
process extension and ramification as well as myelin production. In this context, we 
also intend to develop an automated analysis protocol of OL morphology. Our results 
show a delay in OL process extension when Kank2, Dusp19, PABPC1 and YBX1 
mRNAs are depleted, relatively to control. This delay is characterized by an enrichment 
of cells in earlier stages of differentiation (manual categorization analysis). There is 
also a reduction in the percentage of cells positively stained for MBP (myelin basic 
protein) after depletion of Kank2, Dusp19 and PABPC1 mRNAs. In the case of 
depletion of YBX1, there is a non-significant increase in the percentage of cells with 
MBP staining. Thus, we could conclude that the candidates identified by RNA 
sequencing do have an important role in OL differentiation. 
Keywords 
Oligodendrocyte, myelin, cytoskeleton, RNA-binding proteins, morphological 
differentiation, high-throughput image analysis 
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1. Introduction 
The oligodendrocyte (OL) is the myelinating cell of the central nervous system (CNS). It 
is responsible for the formation and maintenance of myelin sheaths, which enwrap 
axonal internodes, and for trophic support of neurons. Myelin is a lipid-rich substance 
necessary for electric insulation of axons that allows saltatory conduction of nerve 
impulses, making it faster and more energy efficient (Hartline and Colman, 2007).  
Oligodendrocyte-lineage cells arise from the ventral regions of the prosencephalon and 
spinal cord during embryonic development (Kessaris et al., 2006; Noll and Miller, 
1993). In humans, oligodendrocyte progenitor cells (OPC) appear at the forebrain at 10 
weeks of gestation. At around 20 weeks, OPC and pre-oligodendrocytes are the main 
forms of oligodendroglia and, ten weeks later, it is possible to find more complex 
immature OL and a few myelinating mature OL in the subcortical regions (Craig et al., 
2003). At 40 weeks, end of gestation, around 5% of total brain volume is myelinated, 
defining the white matter region (Back et al., 2001). 
OPC are small bipolar cells expressing platelet-derived growth factor receptor α 
(PDGF-Rα) (Pringle et al., 1992) and proteoglycan NG2 at the cell surface (Chittajallu 
et al., 2004; Nishiyama et al., 1996). As they differentiate in vitro, OPC become pre-
oligodendrocytes – multipolar cells with slightly ramified processes expressing 
ganglioside A2B5 at the surface, – immature OL – processes become increasingly 
branched and complex, and cells express sulfatide recognized by O4 antibody 
(Sommer and Schachner, 1981) – and finally mature OL – highly complex cells able to 
produce myelin components such as myelin basic protein (MBP) (Reynolds and Wilkin, 
1988) (Figure 1) (Jackman et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 1 Oligodendrocyte differentiation in vitro and in vivo. Morphological stages found at 0, 3 and 5 days of in 
vitro differentiation (OL0d, OL3d and OL5d). Adapted from Jackman et al. (2009). 
OL0d OL3d 
OL5d 
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1.1. Developmental myelination in the Central Nervous System 
In vivo, pre-myelinating oligodendrocytes emit multiple radially oriented processes 
which reach a maximum distance of 50μm of the cell body (Hardy and Friedrich, 1996). 
These exploratory processes are constantly being extended and retracted as a means 
of sensing the environment until the OL finds a suitable axon to myelinate. Once OL 
establish contacts with appropriate axons, myelination is initiated: the cytoplasmic 
processes begin to spiral around axons to form internodes and the remaining radial 
processes are retracted (Colognato et al., 2002).  
One recent model for myelin ensheathment of axons is called the “liquid croissant 
model” (Sobottka et al., 2011). Just like making a croissant, OL emit triangular 
cytoplasmic processes, which may attach to putative surface molecules on axons, and 
begin wrapping. With each new turn, the inner tongue moves under the outer tongue 
and myelin spreads outwards along the axon, possibly guided by molecules at the 
axonal surface (Figure 2). This model accounts for the irregular texture of internodes 
and for the fact that myelin is thicker in the middle of the internode and thinner at the 
edges.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
While accounting for some characteristics of the internode that had not been previously 
explained, this model fails. A recent work using 3D electron microscopy reconstruction 
showed that the outermost layer of myelin is continuous and the longest (Figure 3) 
(Snaidero et al., 2014). The irregular texture of the internode is due to the organization 
of the inner layers, which are gradually shorter, being the inner tongue the shortest. 
Figure 2 “Liquid croissant” model of axon ensheathment by oligodendrocytes. Yellow – oligodendrocyte process, 
white – axon, blue – putative adhesion molecules on axonal surface. Adapted from Sobottka et al. (2011). 
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Two different motions are at play – the leading edge at the inner tongue wraps around 
the axon while the upper layers extend laterally along the axon.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Such a tightly confined space generates pressure that can help push the leading edge 
forward (blebbing motility) (Paluch and Raz, 2013). However, classic blebbing involves 
actomyosin contractility, which doesn’t exist in OL (myosin is down-regulated (Zhang et 
al., 2014b)), therefore there must be other mechanisms regulating inner tongue 
progression. Indeed, it has been recently found that the actin cytoskeleton is 
disassembled in mature OL, with F-actin (filamentous) limited to the rim of the OL 
membrane, in vitro (Nawaz et al., 2015; Zuchero et al., 2015). In vivo, wild type mice 
spinal cords show early OL membranes wrapping around axons, which are poor in 
myelin basic protein (MBP) and rich in actin, as well as more mature OL membranes 
with an opposite staining pattern (high MBP, low actin). Additionally, shiverer mice 
(knockout for MBP (Readhead and Hood, 1990)) present increased actin staining in 
white matter tracts. The model proposes that, initially, process extension and branching 
rely on Arp2/3-dependent actin assembly: OL treated with Arp2/3 inhibitor show a 
reduced ability to ensheath axons in a dose-dependent manner (Zuchero et al., 2015). 
However, as OL mature and increase the production of MBP, actin staining along 
processes disappears and becomes restricted to the outer rim of the OL membrane. 
Figure 3 Model of a developing myelin sheath. The unwrapped representation shows the shape of the sheath and 
the localization of the cytoplasmic channels. The growth zone is colored in pink and the compacted myelin is in dark 
purple. The wrapped representation shows the position of the layers when wrapped around the axon. The cross-
sections show the state of compaction during myelin growth. Adapted from Snaidero et al. (2014) 
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This is supported by the observation that induced conditional knockout of Arp2/3 during 
ensheathment (10 to 14 days post natal development, P10-P14) doesn’t alter the 
number of myelin wraps in the optic nerve at P30, suggesting that Arp2/3-dependent 
actin assembly is not needed for myelin wrapping. Treating pre-myelinating but 
morphologically differentiated OL with an actin-depolymerizing drug overnight 
dramatically increases MBP production, further suggesting that actin depolymerization 
drives myelination. 
Actin disassembly is usually triggered by depolymerizing factors like gelsolin and cofilin 
(Hilpelä et al., 2004). These proteins are associated with membrane 
phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2 or PIP2) in an inactive state and, when 
PIP2 is hydrolyzed by phospholipase C, they are released to the cytoplasm. However, 
MBP also associates with PIP2 in order to promote myelin compaction (Nawaz et al., 
2009). Therefore, PIP2 hydrolysis does not seem to be the mechanism by which actin 
depolymerizing factors become active. It may be due to a competition between MBP 
and gelsolin/cofilin for the binding to membrane PIP2. An in vitro test using PIP2-coated 
beads incubated with cofilin-1 or gelsolin and increasing amounts of MBP showed that 
MBP was able to compete with the actin depolymerizing factors for binding to the 
beads. This further suggests that MBP binding to PIP2 may be a triggering factor of 
actin cytoskeleton disassembly (Figure 4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4 Model of MBP regulation of actin disassembly during myelination. Actin disassembly factors cofilin and 
gelsolin are normally sequestered by PI(4,5)P2 (PIP2), preventing them from disassembling actin microfilaments (left 
image). MBP binds to PIP2 on the OL membrane, releasing cofilin/gelsolin and triggering actin disassembly (right 
image). Adapted from Zuchero et al. (2015). 
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A similar study (Nawaz et al., 2015) showed that, by depolymerizing the actin 
cytoskeleton, leaving F-actin only at the outer rim, OL create heterogeneous tension 
across the membrane. At the outer rim, tension is greater, generating a force that may 
be able to push the edge further. On the other hand, areas closer to OL soma have 
lower tension, which may allow them to spread out, creating a large myelin sheet. This 
model suggests two steps: first, actin polymerization drives the leading edge forward 
and subsequent depolymerization allows lateral spreading of the myelin sheet. 
Successive cycles of actin polymerization and depolymerization may drive the leading 
edge forward while allowing the spreading of the outer layers (Figure 5). The authors 
identified actin depolymerizing factor (ADF) and cofilin as responsible molecules for the 
regulation of this process. Double knockout OL for ADF and cofilin-1 showed an 
increase in F-actin at the leading edge and a smaller surface area, which was partially 
recovered by actin depolymerizing drugs. In vivo, these animals showed higher 
amounts of F-actin in spinal cord OL. This was accompanied by motor deficits, inner 
tongue enlargement of OL and thinner compact myelin. However, myelin production 
was not completely impaired, which may be due to compensation by other actin 
depolymerizing factors like gelsolin and cofilin-2.  
The close relationship between MBP production and cytoskeleton rearrangements 
shown by the studies of Nawaz et al., 2015 and Zuchero et al., 2015 clearly  
demonstrates how difficult it is to decouple the two mechanisms, myelination and 
process outgrowth of OL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5 Model of actin-driven OL process wrapping. Polymerizing F-actin creates a force that pushes out 
membrane protrusions, squeezing in between the axon and the myelin sheath. Subsequent disassembly of F-actin 
promotes adhesion and spreading of the inner tongue. Successive cycles of actin polymerization and depolymerization 
inflate and deflate the inner tongue (arrows), driving OL process wrapping and myelin membrane formation. Adapted 
from Nawaz et al. (2015) 
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By wrapping membranous protrusions around axons, OL make axonal membranes 
impervious to the passage of ions, which are necessary for the conduction of action 
potentials. Voltage-gated sodium channels are thus relocated to the unmyelinated sites 
(nodes of Ranvier), enabling saltatory (“jumping”) conduction (Figure 6) (Kaplan et al., 
1997; mikeclaffey.com). Saltatory conduction is faster and more energy efficient than 
continuous conduction because the area of membrane to be depolarized is very small. 
However, despite these advantages not all axons are myelinated in the CNS. In fact, it 
is observed that only large caliber axons (greater than 1.3μm in diameter) are 
myelinated, suggesting axon diameter is a selecting factor for OL myelination 
(Windebank et al., 1985). On the other hand, it is also observed that OL promote an 
increase in axonal diameter once myelination is initiated (Colello et al., 1994). This 
evidence shows that the relationship between axons and OL is bidirectional, complex 
and that there is still much to learn about OL differentiation and axonal myelination. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6 Saltatory conduction in nerve fibers. When a nervous impulse reaches a node of Ranvier, voltage-gated 
sodium (Na+) channels open and Na+ ions enter the cell, depolarizing the membrane and pushing pre-existing ions 
inside the cell forward. Then, voltage-gated potassium (K+) channels open, allowing K+ ions to leave the cell, 
repolarizing the membrane. When the flow of ions reaches the next node of Ranvier, voltage-gated Na+ ions open and 
the impulse is propagated. Adapted from mikeclaffey.com 
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Besides the nodes of Ranvier, there are other important regions in axon-OL interaction 
such as the paranodes (Bhat et al., 2001) – promote adhesion between the axon and 
myelin sheath, and limit ion diffusion between the node of Ranvier and the internode – 
and the juxtaparanodes (Poliak et al., 2003) – regions enriched in voltage-gated 
potassium (K+) channels, necessary for membrane repolarization (Figure 7) 
(Buttermore et al., 2013) . 
 
 
 
 
 
 
 
 
 
 
 
Myelin’s main components (70-85% dry weight) are membrane lipids such as 
cerebroside (also known as galactosylceramide), cholesterol and phospholipids like 
ethanolamine-containing plasmalogen (Quarles and Morell, 1999). Proteins such as 
myelin basic protein (MBP), proteolipid protein (PLP), myelin-associated glicoprotein 
(MAG), myelin-oligodendrocyte glycoprotein (MOG) and myelin-associated 
oligodendrocytic basic protein (MOBP) are essential for the formation and maintenance 
of myelin membranes and their dysregulation can lead to pathologies (Figure 8).  
MBP is a positively charged (basic) protein essential for the compaction of myelin 
membranes. Knocking out MBP leads to poorly compacted myelin sheaths, 
hypomyelination and a phenotype characterized by tremors and early death (shiverer 
mouse) (Readhead and Hood, 1990). When injected into an animal, MBP can trigger 
an autoimmune response mediated by T lymphocytes that induces experimental 
allergic encephalomyelitis (EAE), a model of multiple sclerosis (Constantinescu et al., 
2011). MBP messenger RNA (mRNA) is transcribed early during OPC/OL 
differentiation but is kept silent through interaction with heterogeneous nuclear 
ribonucleoproteins (hnRNPs, RNA-binding proteins). Then, it is transported along 
microtubules to the extremities of OL processes until a signal is received to begin 
translation (Hoek et al., 1998; Laursen et al., 2011). MBP interacts with membrane lipid 
PI(4,5)P2 (Nawaz et al., 2009). This interaction with negatively-charged membrane 
causes MBP to self-assemble into a cytoplasmic lattice, which acts as a sieve, allowing 
Figure 7 Structure of the nodal, paranodal and juxtaparanodal regions of axons. Sciatic nerve of a wild-type 
mouse stained for sodium channels, located at the node of Ranvier in green, Caspr adhesion molecule, located at the 
paranode in blue and potassium channels located at the juxtaparanode in red. Adapted from Buttermore et al. (2013). 
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small molecules to pass through its pores while keeping other larger proteins (like 
MAG) out of compact myelin (Aggarwal et al., 2013). The formation of a mesh-like 
structure brings the two cytoplasmic membranes closer, zippering and compacting the 
myelin membrane (Bakhti et al., 2014). 
PLP, as the name indicates, is made of a protein backbone linked to fatty-acids 
palmitate, oleate and stearate (Bizzozero et al., 1986). PLP knockdown has a mild 
phenotype, whereas gene duplication and point mutations cause ultrastructural 
abnormalities of myelin (due to loss of structural support), oligodendrocyte death 
(caused by disrupted protein trafficking) and axonal pathology (due to alterations in 
gene dosage) (Yool et al., 2000).  
MAG is a member of the immunoglobulin superfamily (Arquint et al., 1987). It is present 
at the periaxonal oligodendrocyte membrane where it mediates and maintains contact 
between the two cells (Sternberger et al., 1979). Given its binding affinity to sialic acid, 
MAG is regarded as an adhesion molecule and may be responsible for cell-cell 
interactions necessary for myelin sheath formation and maintenance (Kelm et al., 
1994).  
MOG is also a member of the immunoglobulin superfamily (Gardinier et al., 1992) and 
is localized on the surface of myelin sheaths and oligodendrocytes (Quarles, 2002). 
Along with MBP, PLP and MAG it is a target antigen of T lymphocytes in MS patients 
(de Rosbo et al., 1993). MOBP is a small basic protein found in compact CNS myelin 
(Yamamoto et al., 1994). MOBP-deficient mice generate normal myelin and do not 
appear to have any significant phenotype (Yool et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8 Localization of myelin proteins in the CNS. MBP and PLP are present in compact myelin; MAG is on the 
axon-glia contact surface and MOG on the outer myelin/OL surface. Adapted from Quarles (2002) 
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Even though OL have a low turnover rate (0.3% per year) (Yeung et al., 2014), 
increasing evidence shows that myelin is produced and remodeled throughout life, not 
just during childhood and adolescence. Additionally, this remodeling seems to be 
activity dependent. One example is the comparison between professional pianists and 
same-age control individuals, where it was discovered that pianists had increased 
white matter in brain regions related to learning, hand coordination and visual and 
auditory processing (Bengtsson et al., 2005). Learning a new motor skill is also 
dependent on active myelination and on the adult pool of OPC (8-9% in white matter, 
2-3% in grey matter (Dawson et al., 2003)). Inhibiting the formation of new OL, without 
compromising pre-existing OL and myelin, prevented mice from learning how to run on 
a complex wheel (McKenzie et al., 2014), which suggests that the formation of new OL 
during adult life is another important mechanism for neuroplasticity. Adult OPC exist 
throughout the CNS, namely in the optic nerve (Shi et al., 1998), motor cortex, corpus 
callosum (Clarke et al., 2012) and cerebellum (Levine et al., 1993). They have 
characteristics of stem cells such as self-renewal, production of differentiated progeny, 
multipotency and mitotic quiescence (Alberts et al., 2002b). This means that adult OPC 
proliferate at a slow rate but are able to become activated in response to stress or 
injury, giving rise to mature OL and other cell types like astrocytes (Raff et al., 1983) 
and Schwann cells (Zawadzka et al., 2010).  
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1.2. The oligodendrocyte (OL) cytoskeleton 
In order to exert their functions as myelinating cells, OL need to undergo cytoskeletal 
rearrangements during the processes of differentiation and myelination. The following 
section addresses the composition of OL cytoskeleton and the signaling pathways 
involved in regulating process extension and branching, necessary for morphological 
differentiation of OL. 
 
1.2.1. Tubulin and Actin 
Tubulin is a family of globular proteins involved in the formation of the cytoskeleton. In 
eukaryotes, α- and β-tubulin form heterodimers that constitute microtubules, whereas 
γ-tubulin is a component of the microtubule organizing center located at the 
centrosome (Zheng et al., 1995). 
Microtubules are dynamic filamentous structures. They have a fast-growing end 
(deemed plus (+) end, β subunit is exposed) and a slow-growing end (minus (-) end, α 
subunit is exposed), where α/β tubulin dimers can be added. The flexural rigidity of 
microtubules and their high persistence length make them resistant to deformation and, 
therefore, they are important for maintaining cellular shape (Gittes et al., 1993). Motor 
proteins like dyneins and kinesins travel along microtubules, carrying molecular cargos 
from one cellular location to another (Hirokawa et al., 1998). 
Actin is a globular protein (G-actin), involved in the formation of microfilaments (F-
actin). In most cell types, microfilaments form intracellular networks necessary for 
maintaining cell shape, extending protrusions and migration (Fukui, 1993). Actin 
microfilaments give rise to stress fibers (contractile bundles of microfilaments) (Kreis 
and Birchmeier, 1980), filopodia (spikes at the front of a migrating cell) (Mattila and 
Lappalainen, 2008) and lamellipodia (flat cytoplasmic extensions necessary for motility) 
(Small et al., 2002). 
In oligodendrocytes, actin microfilaments can be found throughout the cell but are 
enriched at the tips of extending processes and in branching sites, especially in 
younger OL relatively to mature ones (Song et al., 2001). Microtubules also exist in the 
cell body and processes, but they do not reach the leading edge of extending 
processes (Figure 9). 
 
 
 
 
 
12 FCUP 
The Oligodendrocyte “processosome”: novel regulators of differentiation and myelination 
 
 
 
 
 
 
 
 
 
 
 
 
It has been concluded that actin microfilaments open the way for microtubules to later 
invade and stabilize newly formed processes. The same was observed for the 
formation of connections between processes during OL maturation – at first these 
connections are established by actin microfilaments and later filled by microtubules. 
Another characteristic of OL cytoskeleton is that microtubules in the cell body and in 
primary processes are rich in acetylated tubulin, which is associated with more stable 
microtubules, while microtubules invading leading edges are enriched in more dynamic 
tyrosinated tubulin (Song et al., 2001). 
In oligodendrocytes, cytoskeleton dynamics is regulated by various signaling pathways, 
of which β1-integrin, Rho GTPases and mitogen-activated protein kinases (MAPKs) will 
be addressed in this thesis. 
 
1.2.2. β1-Integrin signaling 
Integrins are transmembranar proteins that act as adhesion molecules and receptors 
for extracellular matrix (ECM)-based stimuli (Alberts et al., 2002a). 
An integrin receptor is composed of two transmembranar subunits called α and β, for 
which there are many isoforms. Different combinations of α and β subunits interact with 
different ECM components and trigger specific signaling pathways. For example, α6β1 
integrin interacts with ECM laminin whereas α5β1 integrin interacts with fibronectin. 
The cytoplasmic tail of β subunits interacts with the cytoskeleton through anchor 
proteins like talin, α-actinin, filamin and vinculin, which in turn interact with actin 
microfilaments (Figure 10). This interaction can lead to the formation of focal 
adhesions – macromolecular complexes associated with clusters of integrins that 
increase the strength of cell-ECM adhesion. Integrins can activate signaling pathways 
within the cell by recruiting focal adhesion kinase (FAK) and integrin-linked kinase (ILK) 
Figure 9 Oligodendrocyte cytoskeleton. α-tubulin (green) and actin (red) cytoskeleton during in vitro OL 
differentiation (DAPI in blue). Scale bar: 30μm. 
              OL 0d                                   OL 3d                                OL 5d 
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(Legate et al., 2006), which will then recruit and activate other proteins such as 
members of the Src family, PI3K/Akt and MAPK (Alberts et al., 2002a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In OL, integrin expression is temporally coordinated: the first to be expressed, αvβ1, 
contributes to cellular migration during OPC stage. Over-expression of αvβ3 stimulates 
cell proliferation and inhibits differentiation, while antibody blockage of αvβ5 inhibits 
process extension (Blaschuk et al., 2000; Milner and ffrench-Constant, 1994). Finally, 
α6β1 is essential for myelination through interaction with laminin-2 (Buttery and ffrench-
Constant, 1999). In vitro, laminin-2-coated surfaces stimulate the formation of flat 
myelin membranes spreading across the plate and, in vivo, laminin-2 at the axonal 
surface induces OL process wrapping (Buttery and ffrench-Constant, 1999; Colognato 
et al., 2002). 
In OPC stage, Src family kinase Lyn is associated with the αvβ3 integrin-PDGFαR 
complex, activating signaling pathways that promote proliferation (Figure 11, 1). 
However, once axonal contact is established, interaction of α6β1 integrin with laminin-2 
induces dissociation of Lyn and activation of Src family kinase Fyn. Fyn-α6β1 
complexes can interact with PDGFαR or ErBb2/4 receptors and promote OL survival, 
differentiation and myelin formation (Figure 11, 2) (Colognato et al., 2004). 
Additionally, laminin-2-deficient mice present an accumulation of cells in OPC stage, 
Figure 10 Integrin activation and interaction with actin cytoskeleton. Both intracellular and extracellular stimuli can 
trigger integrin signaling. Integrin interaction with anchor proteins (talin and vinculin), IPP complex (ILK, Parvin and 
PINCH) and Src Kinases is necessary for actin cytoskeleton remodeling. Adapted from Legate et al. (2006). 
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accompanied by an increase of Fyn inhibitory proteins (like Csk shown in figure 11) 
and increased phosphorylation of Fyn at an inhibitory site (Relucio et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A dominant negative (DN) chimera of β1 integrin, comprised of the extracellular and 
transmembranar domains of the interleukin-2 receptor and the cytoplasmic tail of β1 
integrin (delivered to OL via retroviral infection), reduces the formation of myelin 
membranes on laminin-2 substrates, but does not interfere with MBP expression timing 
nor with the percentage of MBP+ cells in culture (Relvas et al., 2001). This suggests 
that β1 integrin signaling is necessary for myelination but not for cell survival.  
A conditional knockout experiment in which β1 integrin was excised from OL genome 
(Cre recombinase expressed under 2',3'-Cyclic-nucleotide 3'-phosphodiesterase 
(CNPase) promoter) gave conflicting results (Benninger et al., 2006). In these 
conditions, myelination appeared to be normal in the optic nerve, spinal cord and 
corpus callosum, at 2 and 3 months of age. In addition, re-myelination at 5 weeks after 
lysolecithin-induced spinal cord injury was not impaired in the absence of β1 integrin. 
However, it was observed that premyelinating OL in the cerebellar periphery were 
undergoing increased apoptosis at P5, relative to control animals. Despite this, 
myelination was unaffected in this region at 2 months of age. This conflict may be due 
to the fact that CNPase is expressed in premyelinating OL (Pfeiffer et al., 1993), 
leading to an early deletion of β1 integrin and possibly allowing a compensation by 
other integrins. 
A different DN approach in which mice expressed a β1 integrin lacking the C-terminal 
cytoplasmic tail (β1ΔC) in oligodendrocytes (under PLP promoter) (Lee et al., 2006) 
showed region-specific hypomyelination in optic nerve and spinal cord but an absence 
Figure 11 Switch between proliferation and differentiation in OL is mediated by integrin signaling. Axonal contact 
induces down-regulation of Lyn kinase interaction with αvβ3 and up-regulation of Fyn kinase interaction with α6β1  
Adapted from Colognato et al. (2004). 
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of myelination abnormalities in the corpus callosum. The construct used would bind 
laminin and compete with other receptors on OL surface but would be unable to trigger 
a signaling cascade.  
To try and reconcile these conflicting results regarding β1 integrin function, a third DN 
study was made (Câmara et al., 2009). Here, the construct used only had the 
intracellular domain of β1 integrin. It would not be able to bind its ligand, and 
consequently no signaling would occur. In addition, the authors expressed this 
construct under MBP promoter, thus evaluating only the role of β1 integrin during active 
myelination. In these conditions, it was observed that OL were less efficient in 
myelinating small-caliber axons than wild type or OL over expressing dominant-
negative β3 integrin. However, the thickness and length of myelinated axon tracts was 
normal. Therefore, it was suggested that inhibition of β1 integrin signaling impaired 
initiation but not completion of myelination. This is consistent with the observations 
made by Colognato et al. (Colognato et al., 2002; Colognato et al., 2004).  
Also consistent with these results, conditional ablation of β1 integrin in the CNS (Cre 
recombinase expressed under nestin promoter) and in OL solely (Cre recombinase 
expressed under NG2 promoter) leads to a reduction in myelin sheath thickness in the 
spinal cord, optic nerves and cerebellum (Figure 12) (Barros et al., 2009). This 
phenotype is not due to defects in oligodendrocyte differentiation or survival. When 
these mutant OL are cultured on laminin-2-coated plates and treated with neuregulin-1 
(activator of Akt), Akt is not significantly activated, suggesting β1 integrin is an 
upstream activator of the Akt pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12 OL lacking β1 integrin produce smaller myelin sheets. Morphometric analysis of wild-type (F-F’’) and 
nestinCre-Itgb1-flox (G-G’’) oligodendrocytes showing a smaller area of MBP staining and a shorter process length for 
the knockout. Adapted from Barros et al. (2009). 
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Over-expression of constitutively active Akt in OPC and OL (under PLP promoter) does 
not alter the number of oligodendrocytes produced, but causes a dramatic increase in 
the amount of myelin produced and sustains active myelination in the adult mouse 
(Flores et al., 2008). In β1 integrin-deficient OL, over-expression of constitutively active 
Akt is able to rescue the defect in myelin sheet outgrowth (Barros et al., 2009). 
It can be concluded from these studies that β1 integrin is important for different 
signaling pathways, which need to be temporally coordinated to ensure appropriate OL 
maturation. 
 
1.2.3. Rho GTPases 
Other downstream effectors of β1 integrins are Rho GTPases: a family of small GTP-
hydrolyzing proteins that act as molecular switches: when bound to GTP they become 
active (“on” state) and, after hydrolysis of GTP to GDP, they become inactive (“off” 
state). Guanine nucleotide exchange factors (GEFs) stimulate exchange of GDP for 
GTP to generate the active form and GTPase-activating proteins (GAPs) enhance the 
intrinsic GTPase activity to inactivate the switch (Alberts et al., 2002d). There are 
several members in this family, of which RhoA, Cdc42 and Rac1 are the most studied 
Rho GTPases in mammals. Their function is closely related to actin cytoskeleton 
rearrangements: in fibroblasts, activation of RhoA promotes stress fiber formation 
(Ridley and Hall, 1992), activation of Cdc42 induces filopodia (Nobes and Hall, 1995) 
and activation of Rac1 induces lamellipodia (Ridley et al., 1992). 
During oligodendrocyte differentiation, total levels of RhoA are reduced two- to 
threefold and levels of active (GTP-bound) RhoA are reduced four- to fivefold (Liang et 
al., 2004). Oppositely, both the expression levels and activity of Rac1 and Cdc42 
increase more than twofold throughout differentiation. Consistent with this regulation, 
over-expression of constitutively active (CA) RhoA inhibited OL process extension and 
ramification whereas over-expression of a dominant-negative (DN) form promoted it. 
Again, the opposite was observed when over-expressing CA and DN Rac1 and Cdc42 
(Figure 13).  
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This switch of Rho GTPases is made by integrin-Fyn signaling: upon Fyn activation, 
p190RhoGAP is phosphorylated and activated, inducing RhoA to “switch off” by 
hydrolyzing GTP to GDP. Simultaneously, Fyn activates FAK and leads to activation of 
Rac1 and Cdc42 (Hoshina et al., 2007; Liang et al., 2004; Wolf et al., 2001). 
In vivo, conditional ablation of Cdc42 in OL (Cre recombinase expressed under CNP 
promoter) yielded conflicting results: it led to formation of aberrant myelin outfoldings in 
the spinal cord, optic nerve and corpus callosum (indicative of an important role in 
proper ensheathment and myelination of axons) but had no effect in OPC proliferation, 
directed migration or morphological differentiation (Thurnherr et al., 2006). The same 
method was used to knockout Rac1. Like Cdc42 mutants, Rac1 mutants presented 
myelin outfoldings. Then, it was hypothesized that these two Rho GTPases could have 
synergistic effects in regulating myelination. Therefore, double knockouts with different 
gene-dosage were created (single heterozygous, double heterozygous, single 
homozygous, double homozygous and Rac1 homozygous/Cdc42 heterozygous). It was 
found that single Cdc42 homozygous mice had more myelin outfoldings than single 
Rac1 homozygous mice, Rac1 homozygous/Cdc42 heterozygous had more myelin 
outfoldings than single Rac1 homozygous and that double homozygous had the 
greatest amount of outfoldings of all. These results suggest that Rac1 and Cdc42 
cooperate but are not interchangeable in regulating myelination. 
Figure 13 Over-expression of constitutively active (CA) and dominant-negative (DN) forms of Rho, Rac and 
Cdc42 GTPases. Opposite roles of Rho and Rac/Cdc42 can be observed by the different morphology attained by OL. 
Adapted from Liang et al. (2004). 
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The conflicting results observed for Cdc42 are due to the nature of the methods used. 
Dominant negative mutants of Rho GTPases bind their corresponding GEFs with 
higher affinity than endogenous Rho GTPases, sequestering them. However, they do 
not interact with their downstream targets, making this an unspecific way to “turn off” 
just one Rho GTPase. There may be some contribution of other Rho GTPases to the 
observed phenotype. In the conditional knockout, only one gene is excised from the 
genome, thanks to the loxP sites that flank its sequence. In this situation, one can 
assume with greater certainty that the observed phenotype is related to the genetic 
alteration made. 
Another mediator of integrin-Rho GTPase signal transduction is integrin-linked kinase 
(ILK). ILK is an important component of the macromolecular complex formed at focal 
adhesion sites, which connects extracellular signals to the cytoskeleton and other 
downstream effectors (Brakebusch and Fässler, 2003). Conditional knockdown of ILK 
specifically in OL leads to a delay in both the production of molecular markers of 
maturation (such as myelin-associated glycoprotein, MAG) and in process extension, 
which is accompanied by an increase in active RhoA. This phenotype is partially 
recovered by inhibition of ROCK, an effector kinase of RhoA (O'Meara et al., 2013). 
In summary, RhoA inhibits OL process extension, branching and myelination, whereas 
Cdc42 and Rac1 are necessary to ensure proper formation of myelin layers during OL 
wrapping of axons. 
 
1.2.4. Mitogen-activated protein kinases (MAPK) – JNK pathway 
Many stimuli received by cells are relayed by a cascade of kinases called the mitogen-
activated protein kinase (MAPK) pathway. In this pathway, MAPKs like c-Jun NH2-
terminal kinase (JNK), ERK and p38 are activated by MAPK kinases (MAPKK or MKK) 
and these, in their turn, are activated by MAPKK kinases (MAPKKK) (Schaeffer and 
Weber, 1999). MAPKs have an activation domain called T-loop that consists of 
threonine-X-tyrosine tripeptide, where X can be any amino acid. The threonine (Thr) 
and tyrosine (Tyr) residues must be phosphorylated by MAPKKs for MAPKs to be fully 
activated. MAPK activity is regulated by several proteins including dual-specificity 
phosphatases (DSPs or Dusps), which are able to dephosphorylate both threonine and 
tyrosine residues (Camps et al., 2000). 
JNKs are coded by three genes, Jnk1, Jnk2 and Jnk3, which can be alternatively 
spliced and originate 10 JNK isoforms (Gupta et al., 1996). In JNK, the T-loop has a 
phosphorylation motif Threonine-Proline-Tyrosine and it is phosphorylated by MKK4 
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and MKK7 (preferentially on Tyr and Thr, respectively) (Lawler et al., 1998) (Figure 
14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inhibition of JNK phosphorylation prevents OPC proliferation induced by B104 
neuroblastoma cells-conditioned medium in vitro (Zhang et al., 2014a). c-Jun, a target 
and effector of JNK, suppresses transcription of the MBP gene. However, in Schwann 
cells (the myelinating cells of the peripheral nervous system), this seems to be 
dependent on c-Jun protein levels and not its activation (Parkinson et al., 2008). In any 
case, JNK can regulate the levels of c-Jun as well as its activation (Besirli et al., 2005), 
so repressing the JNK pathway could increase MBP production. A dominant-negative 
form of c-Jun effectively recovers some MBP production after Mitogen/Extracellular 
signal-regulated kinase (MEK)-induced repression of myelin promoter activity, 
suggesting that MEK acts on MBP through c-Jun (Chew et al., 2010). 
Inhibition of JNK also leads to a decrease in microtubule-associated protein 1B 
(MAP1B) phosphorylation in in vitro cultured cortical neurons (Kawauchi et al., 2005). 
MAP1B is a phosphoprotein that interacts with microtubules to regulate their dynamics 
and enable microtubule bundling and elongation. MAP1B can be phosphorylated in two 
Figure 14 The MAPK/JNK pathway in oligodendrocytes. Mitogens like PDGF activate the MAPK signaling cascade. 
Both positive and negative regulators of myelin gene expression are activated: p38MAPK stimulates MBP transcription 
through activation of Sox10 and inhibition of ERK and JNK. ERK and JNK repress MBP transcription through c-Jun. 
Adapted from Chew et al. (2010). 
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modes: mode I makes microtubules more dynamic and can be found in growth 
cones(Goold et al., 1999), whereas mode II leads to the stabilization of microtubules 
and can be found in the proximal regions of growing neurites (Ulloa et al., 1994). In 
neurons, MKK7 mRNA is found at the growth cone of neurites where it can be locally 
translated and activate the JNK pathway (Feltrin et al., 2012). This finding is 
accompanied by a high level of phospho-MKK7, phospho-JNK and phospho-MAP1B at 
the neurites. Knockdown of MKK7 leads to an inability to form microtubule bundles in 
neurites. These findings identify this pathway to be important for axonal outgrowth. 
In oligodendrocytes, MAP1B is expressed during development and precedes the 
formation of flat myelin membranes in vitro (Vouyioukiis and Brophy, 1993). MAP1B 
phosphorylation by JNK is a separate pathway from the one that activates c-Jun. It is 
possible that coordinated activation of c-Jun and MAP1B leads to process outgrowth 
and suppression of MBP translation in earlier stages of OL development. 
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1.3. Local mRNA translation in OL 
Proteins are the building blocks of cells. Whether they are structural or catalytic, they 
are essential for cellular homeostasis and to respond to environmental cues. In all 
types of cells, but especially in highly polarized cells like neurons and 
oligodendrocytes, proteins or their precursor mRNAs must be transported to the 
location where they will exert their functions, such as cytoplasmic extensions (Holt and 
Schuman, 2013).  
mRNAs are produced from the splicing of nuclear pre-mRNAs (Alberts et al., 2002c). 
They are then exported to the cytoplasm where they can either be immediately 
translated into proteins, by interaction with ribosomes, or packaged into 
ribonucleoprotein particles (RNPs) along with specialized RNA-binding proteins (RBPs) 
(Anderson and Kedersha, 2009). These RNPs form granules that are transported along 
microtubules until they reach their final destination. There, RNPs are disassembled and 
mRNAs are translated into proteins. 
The information needed to indicate an mRNA’s destination is contained in its 5’ or 3’ 
untranslated regions (UTRs): non-coding regulatory regions immediately before the 
coding sequence (5’UTR) or between the stop codon and the polyA tail (3’UTR) (Wilkie 
et al., 2003). These sequences must be recognized and bound by RBPs, which keep 
mRNAs protected from translation and degradation as well as mediate interactions with 
molecular motors that transport RNPs (Mangus et al., 2003). The regulatory RNA 
sequences contained in the UTRs can be considered cis-acting factors of RNA 
transport and translation, whereas the proteins that bind them can be considered trans-
acting factors (Shahbabian and Chartrand, 2012). Different combinations of RBPs and 
their relative ratios are important for appropriate targeting and timely unfolding of RNPs 
(Skabkin et al., 2004). This may be a way for cells to coordinate gene expression in a 
cost-effective manner (Keene and Tenenbaum, 2002): all the machinery needed for 
protein synthesis is placed at the site where it will be used, waiting for the appropriate 
signal to begin translation (Willis et al., 2007). 
In OL, MBP is the archetype of a locally synthesized protein (Müller et al., 2013) 
(Figure 15). After transcription and splicing, MBP mRNA is packaged into RNPs 
containing a large number of regulatory and transport proteins, making up RNA 
granules. Proteins such as heterogeneous nuclear ribonucleoproteins (hnRNPs) are 
involved in stabilizing the mRNA, keeping it silenced until it reaches its final destination. 
MBP mRNA contains an A2 responsive element (A2RE) in its 3’UTR, which binds to 
hnRNP A2. This protein seems to have a structural role in assembling RNA granules 
(Han et al., 2010). hnRNP A2 also associates with hnRNP E1 and K (Kosturko et al., 
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2006; Laursen et al., 2011): hnRNP E1 is responsible for maintaining the mRNA 
silenced during transport and hnRNKP K is necessary for the transport of MBP mRNA 
along processes. Knocking-down hnRNP K leads to an accumulation of MBP mRNA at 
branching points in OL processes (Laursen et al., 2011). De-repression of MBP mRNA 
translation seems to be triggered by integrin binding to axonal laminin and activation of 
Fyn kinase. During OL differentiation, hnRNP K associates with transmembranar α6β1 
integrin (Laursen et al., 2011), becomes phosphorylated and releases the mRNA to 
allow translation to occur. Also, Fyn appears to phosphorylate hnRNP A2, stimulating 
the translation of MBP mRNA (White et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The spatial and temporal coordination of the production of myelin components is 
essential for proper myelination of axons. Defects in this process lead to 
hypomyelination or abnormal myelin sheaths (Song et al., 2003), which can cause 
motor impairments, as in the taiep (tremor, ataxia, immobility, epilepsy and paralysis) 
rat mutant (Holmgren et al., 1989). 
Figure 15 Transport and local translation of MBP mRNA. MBP mRNA is packaged into RNA granules with RNA 
binding proteins, motor proteins and parts of the protein synthesis machinery. Then it is transported along microtubules 
towards the OL plasma membrane where Fyn kinase receives axonal signals to locally induce MBP translation. MBP, 
myelin basic protein; A2, F, E1, K, heterogeneous nuclear ribonucleoproteins A2, F, E1, and K; CBF-A, CArG-box 
binding factor A; TOG, tumor over expressed gene; mGluR, metabolic glutamate receptor; NMDAR, NMDA receptor; 
EF1a, elongation factor 1a; ATS, arginyl-tRNA synthetase; 60S/40S, large/small ribosomal subunit; 5’-CAP , 5’  7-
methylguanylate CAP; UTR, untranslated region; AAAAA, Poly A tail. Adapted from Müller et al. (2013). 
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1.4. Transcriptomics of CNS resident cells 
Transcriptomics is the study of cellular mRNA composition (Brent, 2000). It differs from 
genomics, which aims to identify the genetic composition of an organism, and 
proteomics, which looks at cellular protein composition. Like the proteome, the 
transcriptome varies among cell types, changes during the differentiation process and 
can be altered according to changes in environmental context. However, changes in 
transcription can be found prior to changes in protein synthesis. It is therefore important 
to identify which mRNAs are more highly expressed in a given cell type in order to 
understand their function, distinguish subpopulations and anticipate developmental or 
pathological behavior. 
Several studies have compared the transcriptome of the different CNS resident cells: 
neurons, astrocytes, oligodendrocytes, microglia and vascular endothelium. These 
have allowed the identification of novel specific markers to distinguish cell types, as 
well as the demotion of others, found to be less specific than previously thought (Cahoy 
et al., 2008). These studies also allowed the identification of cell type-specific or 
enriched transcription factors and post-transcriptional regulators, such as RBPs, that 
may help us understand how different cell types express their specific differentiation 
programs. Transcriptomics also allows the identification of similarities between cell 
types. For example, pathways involved in axonal guiding, integrin signaling, 
ERK/MAPK, stress-activated protein kinase (SAPK)/JNK and actin cytoskeleton 
signaling are commonly enriched in astrocytes, neurons and OL. Not surprisingly, this 
suggests conserved mechanisms for process extension in all three cell types (Cahoy et 
al., 2008). 
In the particular case of OL, transcriptomic studies have allowed the identification of 
distinct phases of cell differentiation (Dugas et al., 2006). In each of these phases, a 
specific pool of myelin genes and transcription factors is expressed, with tight temporal 
regulation. In OPC stage, most up-regulated genes are related to cell cycle 
progression, DNA synthesis and cytoskeleton. This is to be expected because OPC are 
highly proliferative and migratory cells. As OL mature, these proliferation-related genes 
are down regulated and a different set of genes becomes activated. For example, 
transcription factor Sox10 is up-regulated at early stages of differentiation, inducing the 
production of early myelin protein MBP, whereas zinc-finger protein 536 (Zfp536) (a 
putative transcription factor identified by the authors) is up-regulated in later stages, 
contributing to the production of late myelin protein MOG. Consistently, depletion of 
Sox10 does not alter the levels of MOG, and depletion of Zfp536 does not cause any 
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change in the levels of MBP. This suggests that each step of the differentiation process 
is independently controlled. 
During OPC/OL differentiation process, simultaneously with the up-regulation of myelin 
genes, there is a significant down-regulation of cytoskeletal and matrix genes, as well 
as an up-regulation of genes related to cytoskeleton depolymerization (like gelsolin), 
which are important for myelin compaction (Cahoy et al., 2008; Zuchero et al., 2015). 
Metabolic pathways enriched in oligodendrocytes are 3-phosphoinositide biosynthesis 
and degradation (involved in calcium signaling) (Cahoy et al., 2008). Several 
derivatives of phosphatidylinositol are important for the formation of plasma 
membranes and for intracellular signaling. In the case of OPC, Phosphoinositol 3-
kinase (PI3K) is an important mediator of proliferation, cell survival and prevention of 
differentiation (Ebner and Dunbar, 2000). Additionally, calcium signaling is induced by 
inositol 3-phosphate (IP3) upon activation of muscarinic receptors at the OPC 
membrane (Haak et al., 2002). This may be a mechanism by which neuron activity 
influences OPC migration and differentiation. In OL, phosphatidylinositol-4,5-
bisphosphate (PI(4,5)P2) seems to be necessary for myelin membrane formation 
(Zuchero et al., 2015), as mentioned in a previous section. 
This identification of distinct sets of genes responsible for different steps during OL 
maturation could be useful to study the processes of myelination and re-myelination, 
and to understand why this process fails in the context of demyelinating diseases. 
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1.5. Demyelination and remyelination in Multiple Sclerosis (MS) 
Multiple Sclerosis (MS) is an early onset inflammatory neurodegenerative disease with 
unknown causes (Compston and Coles, 2008; Nave, 2010). It is thought to be 
autoimmune in nature: myelin-specific auto-reactive T-lymphocytes and macrophages 
cross the blood–brain barrier and invade the brain parenchyma accompanied by an 
activation of resident microglia. Inflammation and immune attacks destroy 
oligodendrocytes and myelin sheaths originating lesions in the white matter. These are 
detectable by magnetic resonance imaging and turn into oedematous plaques (sclerae, 
hence the name Multiple Sclerosis) (Figure 16) (Intermountain Medical Imaging).  
 
 
 
 
 
 
 
 
 
 
 
 
Most patients (80%) (Compston and Coles, 2008) suffer acute attacks, accompanied 
by an aggravation of symptoms (relapse) and followed by a recovery (remission), which 
characterizes the relapsing-remitting form of MS (RRMS). The relapse is due to the 
loss of myelin sheaths at internodes, which blocks impulse conduction along the axon 
(McDonald and Sears, 1969), and the remission can be due to the appearance of 
sodium channels along the demyelinated axon (England et al., 1996), remyelination by 
newly recruited OPC (Prineas and Connell, 1979) and resolution of inflammation 
(Redford et al., 1997). The disease can then evolve into a secondary progressive 
phase (SPMS) in which there is a decrease in axonal conduction recovery and an 
irreversibility of symptoms caused by axonal degeneration and inflammation 
(Compston and Coles, 2008). The microenvironment involving the lesion, rich in myelin 
debris, inflammatory cytokines and chemokines, inhibits the differentiation of adult OPC 
and demyelination is accentuated (Brück and Stadelmann, 2003; Kotter et al., 2006). A 
Figure 16 MRI comparing a healthy and an MS patient’s brains. In the picture on the right it is possible to see white 
plaques of demyelination which do not exist in the healthy brain (left). Adapted from www.webmd.com – Magnetic 
Resonance Imaging (MRI) of Multiple Sclerosis. 
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minority of patients (20%) (Compston and Coles, 2008) experience a primary 
progressive form of MS (PPMS) which does not have acute attacks but a progressive 
loss of motor and cognitive abilities. 
OPC and mature OL can be found around the border of active demyelinating lesions, 
but not in inactive, chronic lesions (Kuhlmann et al., 2008). This localization of OPC/OL 
is accompanied by changes in the expression of guiding molecules for OPC migration 
and ECM components (Gutowski et al., 1999; Sobel et al., 1995; Williams et al., 2007). 
These seem to promote OPC recruitment, however, their pattern of expression shifts 
as lesions become chronic, and OPC/OL become unable to repair lesion sites (Chang 
et al., 2002). There is clearly an early attempt to repair demyelinating lesions, but 
somehow the pro-myelinating cues are exchanged by inhibitory signals as the disease 
progresses (Charles et al., 2002; John et al., 2002). 
All therapeutic strategies for MS that have so far been approved by the United States 
Food and Drug Administration are immunomodulatory (Goodin et al., 2002; NMSS). 
They rely on glucocorticoids, interferons (IFNβ), neutralizing antibodies against T-
lymphocytes (alemtuzumab) and inhibitors of DNA synthesis (mitoxantrone and 
teriflunomide) to accelerate recovery and reduce the rate of attacks during the RR 
phase. There are no approved drugs so far that stimulate OPC proliferation and 
myelination. Trials are being conducted to test an anti-LINGO1 antibody (Biogen): 
LINGO1 is a membrane receptor expressed in neurons and OL whose inhibition leads 
to OL differentiation in vitro and in vivo (Mi et al., 2005), as well as remyelination in 
animal models (Zhang et al., 2015).  
Thus, studying OPC/OL normal development can lead to the discovery of novel 
molecules essential for myelination and, therefore to the development of new therapies 
for MS.  
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1.6. RNA Sequencing of Oligodendrocyte soma versus 
processes  
In order to develop better therapies for treating demyelinating diseases, it is 
fundamental to understand the mechanisms underlying OL differentiation and 
myelination. In our lab, we hypothesized that mRNA molecules enriched in the 
processes of OL could have a higher probability of being important for the regulation of 
OL process extension, differentiation and myelination. Therefore, the total mRNA of 
OPC processes and soma was sequenced and compared. To collect the two fractions 
of mRNA, the OPC processes were physically separated from soma using a modified 
Boyden chamber system with chemotactic (PDGF and netrin) and haptotactic (laminin-
2) gradients (Thomsen and Nielsen, 2011) (Figure 17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Bioinformatics analysis of the two transcriptomes showed an asymmetric distribution, 
with a larger number of transcripts being significantly more expressed in the OPC 
processes than in the soma, which was named “processsome” (Figure 18). 
Importantly, two main categories stood out: transcripts related to cytoskeleton 
rearrangements and protein synthesis (Domingues, H.S, unpublished data, not shown). 
Figure 17 Physical separation of OPC soma and processes. Schematic representation of the modified Boyden 
chamber system used to separate OPC soma from processes (top). Scanning electron microscopy images of OPC 
cultured on Boyden chamber membranes: OPC soma on the upper side of the membrane (left) and OPC processes on 
the lower side of the membrane (right) (Domingues, H. S., unpublished data). 
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This reinforced the idea that one of the main events occurring during OPC process 
extension is local protein translation, in particular of mRNAs involved in cytoskeleton 
rearrangements. (Domingues, H. S., unpublished data). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After thorough literature reviewing, four candidate genes were selected for functional 
studies in OL differentiation: Kank2, Dusp19, PABPC1 and YBX1. These were chosen 
based on current knowledge, functionality related to cytoskeleton rearrangements and 
protein translation, availability of commercial reagents such as antibodies and 
differential expression in OPC process vs. soma, expression profile during in vitro 
OPC/OL differentiation and in vivo CNS myelin development (Domingues, H.S. and 
Cruz, A., unpublished data, not shown). Moreover, PABPC1 and YBX1 were identified 
in an in silico screen searching for proteins that bind the 3’ UTRs of mRNAs important 
in OL differentiation. This screen was done using an in-house developed software 
called Protein Binding Site Finder (PBS-Finder http://ilp.fe.up.pt/pbsfinder/) (Cruz, A., 
unpublished data, not shown). PBS-Finder is a user-friendly bioinformatics tool for 
rapid identification and analysis of putative binding sites for RNA-binding proteins 
(RBPs) in mRNAs derived from genome wide studies.  
 
Figure 18 RNA sequencing of OPC soma vs. process. Each dot represents the expression of each transcript, with 
blue dots indicating molecules significantly enriched in the process or soma fractions. The majority of significantly 
enriched transcripts are found in the process fraction (Domingues, H.S., unpublished data). 
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1.6.1. Kank N-motif and ankyrin repeat domain-containing protein 2 or Kidney 
ankyrin repeat domain-containing protein 2 – Kank2 
Kank2, also known as ankyrin repeat domain-containing protein 25 (ANKRD25), 
matrix-remodeling-associated protein 3 (MXRA3) and SRC-1-interacting protein (SIP), 
is an 851 amino acid protein containing an ankyrin-repeat domain. Ankyrin-repeat 
domains are thought to be involved in protein-protein interactions (Sedgwick and 
Smerdon, 1999). The Kank N-motif is conserved in all Kank proteins and contains a 
leucine-rich region and an arginine-rich region (Zhu et al., 2008). There are four 
members of the Kank family, Kank1 to Kank4, with high structural similarities (Figure 
19) (Zhu et al., 2008).  
 
 
 
 
 
 
 
 
 
 
 
Kank1 is the best characterized Kank isoform. It was originally identified in renal cell 
carcinoma (Sarkar et al., 2002) and is responsible for shuttling β-catenin between the 
nucleus and the cytoplasm to induce β-catenin-dependent transcription (Wang et al., 
2006). In the cytoplasm, Kank1 regulates actin polymerization by inhibiting PI3K/Akt 
activation of RhoA through binding to 14-3-3 protein, thus controlling cytoskeleton 
remodeling (Kakinuma et al., 2008). Over-expression of Kank1 in NIH3T3 cells 
significantly reduces the amount of active RhoA. This effect is mediated by interaction 
of Kank1 with 14-3-3 after phosphorylation of Kank1 by PI3K/Akt signaling pathway. 
The reduction in active RhoA levels leads to a decrease in actin polymerization and 
formation of stress fibers. This phenotype can be recovered by over-expression of 14-
3-3, which may saturate Kank1 and possibly leave the remaining 14-3-3 free to interact 
with RhoA activators such as p190RhoGEF (Zhai et al., 2001). Kank1 also inhibits 
Rac1 from interacting with IRSp53 and, consequently, prevents the formation of 
lamellipodia, but doesn’t interfere with the formation of filopodia, in NIH3T3 cells (Roy 
et al., 2009). It also inhibits insulin induced membrane ruffling (NIH3T3 cells), integrin-
mediated cell spreading (NIH3T3 cells) and IRSp53-induced neurite elongation in 
Figure 19 Schematic representations of the structure of human Kank family proteins. Black boxes indicate coiled-
coil motifs, white boxes indicate motifs of the ankyrin-repeats (ANK), and gray boxes indicate the Kank N-terminal (KN) 
motif. Numbers indicate variations of the coiled-coil motifs. Adapted from Zhu et al. (2008).   
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N1E115 (mouse neuroblastoma) cells. Over-expression of all other Kank isoforms (in 
NIH3T3 cells) leads to a reduction in the formation of actin stress fibers, suggesting a 
similar role in regulation of actin polymerization for Kank2, 3 and 4 as observed for 
Kank1 (Zhu et al., 2008) (Figure 20). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Much less is known about Kank2. Its mRNA has been found to be enriched in the 
protrusions of different cell types such as astrocytes processes (Thomsen and Nielsen, 
2011) and NIH3T3 cells pseudopodia (Mili et al., 2008). It has been shown to be 
involved in palmoplantar keratoderma and woolly hair syndrome (Ramot et al., 2014). 
In this disorder, alanine 670 is replaced by valine. This mutation may make Kank2 
unable to sequester steroid receptor co-activators in the cytoplasm, leading to an 
increase in vitamin D receptor signaling. Recently, Kank2 was found to be involved in 
steroid resistant nephrotic syndrome. In this disease, serine 181 is substituted by a 
glycine residue (Gee et al., 2015). A co-immunoprecipitation assay showed that wild-
type Kank2 interacts with RhoGDI (Rho GDP-dissociation inhibitor) in human 
podocytes, and that a mutated form increases the binding of RhoGDI to small 
RhoGTPases like RhoA, Cdc42 and Rac1. On the other hand, knockdown of Kank2 led 
to an increase in active RhoA, but not Rac1 nor Cdc42, and a decreased migratory 
phenotype in mouse podocytes. Given the role of RhoA in modulating actin 
cytoskeleton dynamics in OL, Kank2 could be an important regulator of OL process 
extension and/or myelination. 
  
Figure 20 Over-expression of Kank2-4 reduces the formation of actin stress fibers. NIH3T3 cells over-expressing 
Kank2-4 (green) present lower staining of actin cytoskeleton (red). Scale bar: 20μm. Adapted from Zhu et. al (2008). 
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1.6.2. Dual specificity phosphatase 19 – Dusp19 
Dual-specificity phosphatase 19 (DUSP19) also known as stress-activated protein 
kinase pathway-regulating phosphatase 1 (SKRP1) and low molecular weight dual 
specificity phosphatase 3 (LMW-DSP3) (Cheng et al., 2003), is a 217-amino acid 
protein able to dephosphorylate both tyrosine and serine/threonine residues. Not much 
is known about Dusp19. It is a MAPK phosphatase involved in the JNK pathway (Zama 
et al., 2002a). Dusp19 interacts directly with MKK7, an activator of JNK, in order to 
dephosphorylate its biological substrate JNK and thus inhibiting the pathway. Dusp19 
may also act as a scaffold protein (Zama et al., 2002b): expression of Dusp19 within a 
defined range inhibited the activation of MKK7, but the over-expression promoted the 
activation of the pathway. In neurons, MKK7 mRNA localizes to neurite growth cones 
and its localized translation enables the activation of JNK/MAP1B signaling (Feltrin et 
al., 2012). Active MAP1B promotes microtubule bundling and neurite elongation. 
Considering the role of JNK in OPC proliferation (Zhang et al., 2014a), MBP production 
(Chew et al., 2010) and modulation of microtubule dynamics (Feltrin et al., 2012), it is 
possible that Dusp19 plays a role in OL differentiation and myelination via the signaling 
complex assembly of ASK1/MKK7/JNK as a scaffold protein and/or in the 
dephosphorylation of JNK (Figure 21). 
 
 
 
 
 
 
 
 
 
 
 
 
 
ASK1 
or 
Dusp19 
Figure 21 Possible roles of Dusp19 in JNK pathway. Dusp19 may regulate the JNK pathway by direct 
dephosphorylation of JNK or by interfering with the assembly of signaling complexes involving MKK7 and ASK1. 
Adapted from Chew et al. (2010). 
Dusp19 
 
MAP1B 
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1.6.3. PolyA-Binding Protein Cytoplasmic 1 – PABPC1  
PolyA-Binding Protein Cytoplasmic 1 (PABPC1) is a 636 amino acid protein that binds 
to all polyA tails of mRNAs in the cytoplasm. Its function is to protect mRNAs and 
regulate their translation/degradation (Mangus et al., 2003). PABPC1 also binds to the 
3’ UTRs of many mRNAs, independently of binding to PolyA tails. It stimulates 
translation by recruiting ribosome subunits (Kahvejian et al., 2005) and prevents mRNA 
degradation by protecting the PolyA tail and impeding deadenylation (Ford et al., 
1997). PABPC1 is necessary for the formation of RNPs, which transport mRNAs along 
microtubules to the location where they will be translated (Dai et al., 2012). It is also 
part of the machinery behind microRNA-mediated regulation of translation and 
nonsense-mediated mRNA decay (Nicholson and Mhlemann, 2010). PABPC1 is 
necessary for the expression of other RBPs like YBX1 (Skabkina et al., 2003). 
Depletion of PABPC1 mRNA in HeLa cells led to inhibition of mRNA translation but not 
transcription nor transport (Zannat et al., 2011). Cells showed no changes in mRNA 
levels but protein synthesis was so strongly impaired that cells eventually underwent 
apoptosis. Over-expression of PABPC1 reduced the levels of several mRNAs, 
including MAP Kinase MKK2, by altering their stability (Ma et al., 2006). As a result, 
MKK2/ERK-mediated phosphorylation of PABPC1 was down-regulated and this acted 
as a feedback mechanism to prevent deleterious effects of excess PABPC1. In OL, 
PABPC1 can bind to the 3’UTR region of most early and late markers of differentiation 
such as NG2, Olig1 and 2, PDGFRα, CNP, MBP, MOBP, MOG, MAG and PLP1 (Cruz, 
A., in silico analysis, unpublished data). Therefore, it could be an important regulator of 
OL process extension, branching and myelination. 
 
1.6.4. Y-Box binding protein 1 – YBX1 
Y-Box binding protein 1 (YBX1) is a 323 amino acid protein that binds to promoter 
regions containing a Y-box sequence (5'-CTGATTGGCCAA-3'). It binds both DNA and 
RNA molecules and is involved in processes such as DNA replication, transcription and 
repair, pre-mRNA splicing and translation. In the cytoplasm, YBX1 can act as a 
packaging protein of RNPs and it regulates translation in a dose-dependent manner – 
at high YBX1-mRNA ratios it inhibits translation and at low ratios it promotes 
translation, by unfolding RNPs and making the mRNA accessible to translation 
initiation factors and ribosomes (Minich and Ovchinnikov, 1992; Skabkin et al., 2004). 
In OL, YBX1 can bind to the 3’UTR region of early markers of differentiation such as 
Olig1 and 2, PDGFRα and CNP, and to late markers MBP and MOBP (Cruz, A., in 
silico analysis, unpublished data). YBX1 may act as a promoter of translation of the 
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early markers and an inhibitor of the later ones, until the cell receives an appropriate 
signal to begin myelination. 
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1.7. Image analysis for morphological studies 
Studies of cellular morphology require visualization of their architecture. This can be 
achieved by immunostaining of cytoskeletal components such as microtubules and 
actin microfilaments followed by microscopy. These microphotographs then have to be 
analyzed for morphological features and any differences found relative to the control 
phenotype can then be used as evidence to support or discredit a hypothesis. 
 
1.7.1. Manual Categorization 
One possible method to characterize cell morphology is by categorization (Thurnherr et 
al., 2006). An arbitrary number of morphological categories can be established and the 
criteria used to create these categories must be adapted to the model and reflect the 
different phenotypes or behaviors observed. It is a simple and low-tech method. All that 
is needed are pictures of the cells in the sample and a spreadsheet to count the 
number of cells assigned to each category for each experiment. However, despite 
being easy, this method is not without limitations. It is time consuming and biased to 
the user’s observation skills, opinion and experience. It is a method that takes training 
– a more experienced user will have a different opinion of what he is observing and he 
will have a different result than a less experienced user. Another limitation is that cells 
don’t have defined phenotypes: they lie on a spectrum that can range from less 
differentiated immature cells to fully differentiated and complex mature ones (taking 
OPC/OL as an example, Figure 22). This type of analysis is qualitative rather than 
quantitative and the information obtained depends on the categories created.  
 
 
 
 
 
 
 
 
 
  
          1                          2                          3                          4                          5 
Figure 22 Branching categorization of OPC/OL. OPC/OL increasing morphological complexity throughout 
differentiation can be analyzed by assigning cells to different stages of development. Adapted from Thurnherr et al. 
(2006). 
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1.7.2. Sholl Analysis 
Sholl Analysis is a quantitative method used to analyze highly polarized cells like 
neurons and oligodendrocytes. First published by D. A. Sholl in 1953 (Sholl, 1953), it 
consists in overlapping a series of equidistant, concentric circles with an image of a 
branched cell (Figure 23) (Binley et al., 2014). The circles should be centered at the 
cell body and the number of intersections between each circle and the processes are 
quantified.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The average number of intersections for each circle is further plotted against the 
distance from the soma. This originates a curve with a peak representing the critical 
value (radius at which there is a maximum number of intersections) and the maximum 
number of processes. The first point in the graph represents the number of primary 
processes and the ratio between the maximum number and this primary number gives 
a measure of the branching degree (Schoenen Ramification Index). A shift in the 
position of the peak along the x-axis (Sholl Ring radius) indicates an earlier (shorter 
distance) or later (longer distance) production of branches, whereas a shift along the y-
axis (average number of intersections) indicates an increase or decrease of branching 
(Figure 24).  
Nowadays, there is software which can semi-automate this technique, like FIJI’s Sholl 
Analysis plugin (Ferreira et al., 2014; Schindelin et al., 2012).  
Sholl Analysis is an accurate way to achieve quantitative data from samples. However, 
it is a very time consuming technique, since it can only analyze one cell at a time, and it 
can be biased because it depends on the user’s choice of which cells to analyze.  
 
 
Figure 23 Sholl Analysis of a neuron. A fluorescence image of a neuron (A) is traced over to outline the dendrites and 
the axon (arrow) (B). Then, regularly spaced circles are superimposed with the traced pictures, centered at the cell 
body, and the number of intersections between the circles and the dendrites is determined (C). Adapted from Binley et 
al. 2014 
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1.7.3. High-throughput Image Analysis 
The two methods previously described are time consuming, reducing the number of 
cells analyzed in a useful time frame, and biased to the user’s observations and choice 
of which cells to analyze and which to ignore. To solve these limitations, some 
companies have developed automated image analysis software to enable a high 
throughput image analysis.  
The INCell Developer Toolbox software (GE Healthcare) was used in this thesis 
(Healthcare, 2008a). It is associated to the INCell Analyzer fluorescence microscope 
and it is designed to obtain a great amount of information from images acquired with 
the microscope. This microscope has several acquisition modes, like 2D (separate files 
for each individual plane along the z-axis, which must later be projected together) and 
3D (a single file including all the planes acquired along the z-axis) (Healthcare, 2008b). 
In addition, it also has a 2.5D mode: it is an intermediate between 2D acquisition (low 
quality, low file size but requires post-processing) and 3D (high quality but large file 
size and lower acquisition speed). It acquires a “thick slice” that begins above and ends 
below the focus point, projects it onto a single plane and outputs a deconvoluted image 
(Figure 25).  
 
 
 
 
 
 
Figure 24 Sholl Profile of neurons. 62 cells were analyzed using the Simple Neurite Tracer plugin of FIJI. Adapted 
from Binley et al. (2014). 
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In order to reduce the file size even further, camera binning can be used (Healthcare, 
2008b). For example, a 2x2 binning converts each set of 4 pixels in the original image 
created by the camera to a single pixel in the saved image (resolution is reduced to 
one-fourth).  
The INCell Developer Toolbox software comes with pre-established analysis modules 
for common studies such as cell cycle progression, membrane trafficking and neurite 
outgrowth. INCell Developer Toolbox also allows the user to define his own protocol to 
answer questions that may not be covered by the analysis modules. In this situation, 
the user can explore the many tools offered by the software to manipulate fluorescent 
images in order to make cells and their features more “visible” to the software (Table 
1). After pre-processing, grey-scale images can be segmented based on a single 
thresholding operation (object segmentation) or multiple operations (intensity 
segmentation), depending on the target’s characteristics. The targets can be nuclei, 
vesicles, processes, etc. During segmentation, the user can define exclusion 
parameters such as minimum intensity and form factor (circularity of the target). 
After segmentation, targets can be further processed to enhance their characteristics. 
For example, if cells are in very close proximity they can clump together, making it 
difficult to identify intercellular boundaries. A “clump breaking” operation can be used to 
separate adjacent cells. The software also includes a series of macros the user can 
apply to process and combine different targets. A macro is a set of program commands 
that is performed automatically, simplifying complex or repetitive tasks. For example, it 
is possible to use a macro to take a total cell and subtract the cell body in order to keep 
only the processes for further processing or analysis. 
 
 
 
 
 
 
Figure 25 2.5D image acquisition mode. Image acquisition begins above the focus point and ends below. Then, the 
image is projected onto a single plane and deconvoluted (Healthcare, 2008b) 
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Table 1 Some image processing tools available in INCell Developer Toolbox software. 
Tool Name Function 
Pre-processing 
Denoising 
(gradient) 
A higher degree of smoothing is applied to areas of the image 
where the gradient is small (e.g., in background) than in areas 
where the gradient is steep (e.g., across edges). 
Segmentation 
Intensity 
segmentation 
Segments pixels within a defined range of fluorescence 
intensities, set by the user 
Object 
segmentation 
Uses kernels: sets of at least 9 pixels (3x3) in which the center 
pixel is replaced by the value computed using the eight pixels 
that surround it. 
Post-processing 
Sieve Filter that removes objects that are too big or too small and do 
not correspond to real targets 
Dilation Enlarges boundaries of regions of foreground pixels increasing 
their size while holes within those areas become smaller 
Erosion Shrinks a region’s outer boundary whilst at the same time 
enlarging any holes within it 
Clump breaking Uses a secondary target, such as the nucleus, to identify 
cellular borders. The boundaries between neighboring cells are 
calculated at the equidistance from each nucleus, and then 
imposed onto the cell segmentation image 
 
 
After segmentation and post-processing, the user can link several targets together. For 
branched cells, for example, it makes sense to link one cell body to many processes 
but only one nucleus to one cell body. Then it is possible to define which 
measurements the software should make from the data. There are many pre-
established measurements such as density levels (mean pixel intensity within a target), 
target area, target length, number of branch nodes and end nodes (for fibrous shapes 
like cellular processes), etc. The user can also create classifiers to organize the data in 
a manner easier to interpret, for example GFP+/GFP- cells, according to an arbitrary 
fluorescence intensity threshold. Finally, all the data obtained from the image analysis 
can be exported in a spreadsheet-type file, such as an Excel file for later statistical 
analysis of results. This software is an example of a high-throughput image analysis 
system given the short amount of time needed to obtain a large amount of information. 
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1.8 Aim 
The specific aims of this Master thesis are the following: 
1. Develop an automated high-throughput protocol for image analysis to study OL 
morphology and myelin production 
2. Study the functional role of Kank2, Dusp19, PABPC1 and YBX1 in in vitro 
OPC/OL differentiation and myelination. In particular, evaluate the role of these 
molecules in OL process extension and myelin production 
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2. Materials and Methods 
 
2.1. Reagents 
Buffers: 
Phosphate Buffer Saline (PBS): 137mM NaCl (VWR), 2.7mM KCl (Merck Millipore), 
10mM Na2PO4·7H2O (Merck Millipore), 1.7mM KH2PO4 (Alfa Aesar), pH 7.3-7.4. 
 
Microtubules-protecting (MP) buffer: 65mM PIPES (Millipore), 25mM HEPES 
(Sigma), 10mM EGTA (brand), 3mM MgCl2 (Sigma), pH 6.9.  
 
MP-PFA 4%: 40g paraformaldehyde (Sigma) in 1L MP buffer. 
 
Cell culture media: 
Complete Dulbecco’s Modified Eagle Medium (cDMEM): DMEM high glucose 
GlutaMAX™ Supplement (Gibco) supplemented with 10% Fetal Bovine Serum (FBS, 
Sigma) and 1% penicillin/streptomycin 10000U/mL (Gibco). 
 
SATO medium: 1 mg/mL human apo-transferrin (Sigma), 1 mg/mL bovine serum 
albumin (NZYtech), 0.16 mg/mL putrescin dihydrochloride (Sigma), 0.0012 μg/mL 
progesterone (Sigma), 0.008 μg/mL sodium selenite (Sigma), 0.008 μg/mL L-thyroxine 
(Sigma), 0.006 μg/mL triiodothyronine sodium salt (Sigma) in DMEM high glucose 
GlutaMAX™ Supplement (Gibco). 
 
OPC SATO medium: SATO medium supplemented with 1% penicillin/streptomycin 
10000U/mL, 10 ng/mL recombinant human fibroblast growth factor-basic (Peprotech), 
10 ng/ml recombinant human platelet-derived growth factor AA (Peprotech) and 
5μg/mL recombinant human insulin solution (Sigma). 
 
OL SATO medium: SATO medium supplemented with 1% penicillin/streptomycin 
10000U/mL, 0.5% FBS and 5μg/mL recombinant human insulin solution (Sigma). 
 
Blocking Solution for Immunocytochemistry (ICC) 
5% Normal Goat Serum (Invitrogen) in PBS. 
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2.2. Mixed Glial Cell Cultures 
This protocol was based on the works of Chen et. al (2007) and McCarthy and de Vellis 
(1980) with adaptations (Chen et al., 2007; McCarthy and de Vellis, 1980).  
Mixed glial cell cultures were obtained from isolating the brain cortices of P1-P2 (1-2 
post-natal days) Wistar rats. Pups were euthanized by decapitation using a pair of 
scissors. Then, the skull was cut open, starting at the foramen magnum, forward along 
the sagittal suture and then towards either side of the skull to expose the brain. 
Afterwards, brains were scooped out using a pair of curved tweezers into chilled 
Hank’s Balanced Salt Solution (HBSS, Gibco) supplemented with 1% 
penicillin/streptomycin 10000U/mL. Next, brains were dissected to remove the 
meninges and isolate the cortex. Isolated cortices were first mechanically homogenized 
by pipetting up and down using a serological pipette and a syringe with a 25G needle. 
Then, the cells were enzymatically treated with 0.1mg/mL DNAse I (Sigma) and 
0.0025% trypsin (Gibco) in HBSS for 15 minutes at 37ºC. Reaction was stopped with 
serum-containing DMEM and cells were then centrifuged (Heraeus Megafuge 1.0) at 
500g for 10 minutes. The supernatant was discarded and the cells were re-suspended 
in complete DMEM and filtered through a 100μm nylon cell strainer (BD Falcon) into 
50mL sterile centrifuge tubes (Fisher). Finally, the cell suspension was plated on poly-
D-lysine (PDL)-coated (Sigma) T75 flasks (Sarstedt) at a concentration of 2 brains per 
flask. Flasks were cultured in complete DMEM medium at 37ºC in 5% CO2 for 
approximately 10 days. Medium was replaced every 2-3 days.  
 
 
2.3. Oligodendrocyte Progenitor Cells isolation and culture 
After approximately 10 days, a mixed glial cell culture consists of a confluent layer of 
astrocytes on top of which OPC and microglia grow. OPC do not differentiate because 
astrocytes produce large amounts of PDGF (Moore et al., 2011). At this time, culture 
flasks were pre-shaken at 200 rpm and 37ºC for 2 hours (INFORS HT Minitron 
incubator shaker) to remove microglia cells. Afterwards, flasks were shaken at 220 rpm 
overnight to collect OPC. Depending on the intended analysis, OPC were plated in 
PDL and laminin-2 (human merosin, Milipore)-coated 6-well plates (Thermo Scientific); 
60mm Ø Petri dishes (Orange Scientific) or 18 mm Ø HCl-treated glass coverslips 
(Thermo Scientific) (day -2). OPC were cultured in OPC SATO medium for 2 days to 
enable cell synchronization and promote proliferation. OL differentiation was induced 
by replacing the medium with OL SATO (day 0). In general, cells were collected for 
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analysis at day 0 (OPC stage, OL 0d), 3 (immature OL, OL 3d) and 5 (myelinating 
mature OL, OL 5d) post-differentiation. 
 
 
2.4. Lentivirus production and OPC infection 
This protocol was based on the protocol by Tiscornia et al. (2006) with adaptations 
(Tiscornia et al., 2006). Lentiviral vector particles were produced using packaging 
HEK293T cells. Cells were transfected with three different plasmids: lentiviral pSicoR 
plasmids (Addgene plasmid # 11579 (Ventura et al., 2004)) carrying shRNA sequences 
and a green fluorescent protein (GFP) reporter tag, psPAX2 plasmid (Addgene plasmid 
# 12260, Didier Trono) carrying genes coding for lentiviral packaging proteins and 
pCMV-VSV-G plasmid (Addgene plasmid # 8454 (Stewart et al., 2003)) containing 
genes coding for envelope proteins. The transfection reagent used was jetPRIME 
(Polyplus). Lentiviral particles were collected from the cell culture supernatants 2 days 
post-transfection and the viral titer was determined by Fluorescence-activated cell 
sorting (FACS): HEK293T cells were infected with 10 fold dilutions of virus suspension 
and the percentage of GFP positive (GFP+) cells was determined by flow cytometry 
using FACSCalibur (BD Biosciences). The viral titer was calculated by  
 
𝑇𝑈 𝜇𝐿⁄ =
𝑃 × 𝑁
100 × 𝑉
×
1
𝐹
 
where:  
TU=transducing units 
P =% GFP+ cells 
N= number of cells at time of transduction 
V=volume of supernatant added to each well 
F= dilution factor 
 
OPC were infected with shRNA-loaded virus for the depletion of Kank2 and Dusp19 on 
the same day that they were plated (day -2). OPC were transduced with the shRNAs 
for the depletion of PABPC1 and YBX1 on the day of OL induced differentiation (day 
0). A shRNA against dsRED fluorescent protein was used as infection control. Cells 
were infected using a multiplicity of infection (MOI, ratio of virus particles to cells) of 
1:1. 
The Kank2, YBX1 and PABPC1 shRNA sequences (Table 2) were designed by 
pSicoOligomaker 1.5 software (http://jacks-lab.mit.edu/protocol/psico). The shRNA 
sequence for Dusp19 was validated by Sigma (Clone Number: TRCN0000081192). 
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The shRNA sequences were cloned into the lentiviral pSicoR vector (Addgene) using 
HpaI-XhoI cleavage sites (Domingues, H.S and Cruz, A., unpublished data).  
 
Table 2 shRNA sequences for mRNA knockdown. 
Gene shRNA Sequence (5’ – 3’) 
dsRED AGTTCCAGTACGGCTCCAA 
Kank2 GCTTGGCCCTGGAGAAATA 
Dusp19 GACCACGCTAACTGGAAAGAA 
PABPC1 GTAACATCCTTTCATGTAA 
YBX1 GAGAACCCTAAACCACAAGAT 
 
 
2.5. RNA isolation and cDNA synthesis 
RNA was isolated from OL cultures using Quick-RNA MicroPrep kit (Zymo Research) 
or TRIzol reagent (Invitrogen). Briefly, cells were lysed using Quick-RNA MicroPrep 
RNA Lysis buffer and a cell scraper. Then, RNA was purified by mixing with an equal 
volume of ethanol, placing the mixture in a purification column and centrifuging with 
RNA Prep buffer, followed by RNA Wash buffer (twice). Finally, RNA was eluted from 
the column using RNAse-free water. Afterwards, RNA concentration was determined 
by spectrophotometry (NanoDrop 1000, Agilent).  
RNA extraction using TRIzol was performed as follows: cells were lysed in 500μL 
TRIzol, let at room temperature for 5 minutes and frozen at -80°C. Afterwards, samples 
were thawed at room temperature, mixed with 100μL chloroform and vortexed. The 
mixture was allowed to incubate for 3 minutes at room temperature and then 
centrifuged at 12000g, 4°C for 15 minutes. The aqueous phase was transferred to a 
new tube (on ice) and 1μL Glycoblue (15mg/mL) was added to each sample. Then, an 
equal volume of isopropanol was added, the mixture was vortexed and frozen at -80°C. 
Samples were thawed at room temperature, centrifuged at 12000g, 4°C for 20 minutes 
and the supernatant was removed. The pellet was washed with 500μL chilled ethanol 
75% and centrifuged at 12000g, 4°C for 10 minutes. Ethanol was removed and the 
RNA pellet was re-suspended in 15μL nuclease-free water. The solutions were 
incubated on ice for 3 min, pipetting up-and-down every 30s. An aliquot was taken from 
each sample to quantify and the remainder was stored at -80°C.  
cDNA synthesis was then performed using SuperScript III First-Strand Synthesis 
Supermix for quantitative real-time PCR Kit (Invitrogen) following the manufacturer’s 
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instructions and using C1000 Thermal Cycler (Bio-Rad). Up to 1μg of RNA was mixed 
with 10μL RT reaction mix, 2μL RT Enzyme mix and diethylpyrocarbonate (DEPC)-
treated water, up to a final volume of 20μL. The mixture was incubated at 25°C for 
10min, followed by 50°C for 30min and 85°C for 5min. Then, the reaction mixture was 
cooled, 1μL of RNAse H was added and the mixture was incubated for 20min at 37°C. 
 
 
2.6. Quantitative Real-Time Polymerase Chain Reaction 
Quantitative real-time PCR (qPCR) was performed using iQ SYBR Green Supermix 
(Bio-Rad) and iCycler iQ5 Real-Time PCR machine (Bio-Rad). The supermix contains 
deoxynucleotides (dNTPs), iTaq DNA polymerase, MgCl2 and SYBR Green dye. For 
each gene, reaction mixtures were prepared as follows: 0.5μL of forward and reverse 
primer solutions (10μM) were mixed with 10μL iQ SYBR Green Supermix 2X, 1μL of 
cDNA (pre-diluted 1:3) and 8μL of nuclease-free water to a final volume of 20μL. 
YWHAZ or GAPDH were used as reference genes and 9μL of pure water were used as 
no-template control. qPCR was performed using iCycler iQ5 and consisted in 3 minute 
incubation at 94°C for polymerase activation and DNA denaturation followed by 40 
cycles of amplification – 15s at 94°C, 20s at 60°C and 15s at 75°C. Melting curve was 
obtained by heating the sample from 55°C to 95.5° (step 0.5°C, 81 cycles) to confirm 
PCR product specificity. 
Primer sequences are shown in  
Table 3. 
 
 
Table 3 Primer sequences used for qPCR. 
Gene Primer Forward Primer Reverse 
Kank2 GGAGGAAATTCGGATGGATCTG ACTTTCAGTTCTCGCTCTGTGA 
Dusp19 ACCTGCAAGTTGGCGTTATTA TGGTTTCAGGCACATCCAGTAT 
PABPC1 AACCGTGCTGCATACTATCCT GCATATTCTGGAATGGATGAGGTC 
YBX1 GAAGGAGAAAAGGGTGCGGA TGGTAATTGCGTGGAGGACC 
YWHAZ GATGAAGCCATTGCTGAACTTG GTCTCCTTGGGTATCCGATGTC 
GAPDH  TGGAGTCTACTGGCGTCTT TGTCATATTTCTCGTGGTTCA 
MBP GCTCCCTGCCCCAGAAGT TGTCACAATGTTCTTGAAGAAATGG 
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2.7. Immunocytochemistry (ICC) 
OL were collected on days 0, 3 and 5 post-induction of differentiation (OL 0d, OL 3d 
and OL 5d). Cells were fixed with 4% paraformaldehyde in MP buffer for the 
preservation of the cytoskeleton integrity. Afterwards, cells were permeabilized in 0.1% 
Triton X-100 in PBS for 10 minutes at room temperature and incubated in blocking 
solution for 1h at room temperature. Then, samples were incubated with primary 
antibodies (Table 4) diluted in blocking solution overnight at 4ºC, washed 3 times in 
PBS for 5 minutes each, followed by 1h incubation at room temperature with 
fluorescent-conjugated secondary antibodies (Table 4) and/or Alexa Fluor 594 
Phalloidin (Molecular Probes). Finally, samples were washed 3 times in PBS for 5 
minutes, the nuclei were counterstained with DAPI (1:20000) (Invitrogen) for 10 
minutes, washed again twice in PBS and mounted on glass slides using Immu-Mount 
mounting medium (Thermo Scientific). Olig2, an oligodendrocyte-specific transcription 
factor, was used as a marker of OPC/OL, to analyze exclusively OPC/OL and not 
contaminating cells such as microglia and astrocytes. For morphological analysis, 
samples were stained with anti-Olig2 and anti-α-tubulin antibodies. For MBP analysis, 
samples were stained with anti-Olig2 and anti-MBP antibodies. 
 
Table 4 List of primary antibodies, secondary antibodies and stains used for immunocytochemistry. 
 
Primary Antibodies 
Antigen 
Animal of 
origin 
Dilution Product reference 
α-tubulin Mouse, mAb 1:2000 T5168, Sigma 
Olig2 Rabbit, pAb 1:500 
AB9610, Chemicon 
International 
MBP Rat, mAb 1:100 MCA4095, AbD Serotec 
Secondary Antibodies 
Antigen 
Conjugated 
fluorophore 
Animal of 
origin 
Dilution Product reference 
Mouse IgG 
Alexa Fluor® 
647 
Goat, pAb 1:1000 
A-21236, Life 
Technologies 
Rabbit IgG 
Alexa Fluor® 
568 
Goat, pAb 1:1000 
A-11036, Life 
Technologies 
Rabbit IgG 
Alexa Fluor® 
647 
Goat, pAb 1:1000 
A-21236, Life 
Technologies 
Rat IgG 
Alexa Fluor® 
568 
Goat, pAb 1:1000 
A-11077, Life 
Technologies 
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2.8. Image acquisition 
For morphological and MBP analysis of OL, fluorescent images (four channels – DAPI, 
FITC, Texas Red and Cy5) were obtained using In Cell Analyzer 2000 widefield 
microscope (General Electric), a 20X objective and 2.5D acquisition mode.  
Between 36 and 100 fields were obtained per sample, corresponding to the analysis of 
at least 1000 cells. Exposure times were adjusted for each experiment, but maintained 
for all samples within experiments, to allow comparison of results. 
Images representative of quantitative results were obtained using the Laser Scanning 
confocal microscope Leica TCS SP5 II (Leica Microsystems, Germany) or the wide-
field fluorescent microscope Leica DMI 6000B (Leica Microsystems, Germany). 
Images representative of results were edited using ImageJ. Fluorescence intensity was 
adjusted to increase contrast and avoid overexposure and the image stack was 
merged using a maximum projection of each plane. Planes that were out of focus were 
rejected.  
 
 
2.9. Image Analysis using INCell Developer Toolbox software 
The INCell Developer Toolbox software was used to perform high-throughput image 
analysis of pictures obtained using the INCell Analyzer 2000 microscope. Several 
protocols were produced to study OL morphology and the production of MBP in the 
context of shRNA-mediated knockdown of Kank2, Dusp19, PABPC1 and YBX1. These 
protocols were under optimization and will be, therefore, further described in detail in 
Section 3. 
 
 
 
 
Stains 
 Dilution Product reference 
4',6-diamidino-2-
phenylindole 
(DAPI) 
1:20000 D1306, Life Technologies 
Alexa Fluor® 
594 Phalloidin  
1:100 A12381, Life Technologies 
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2.10. Morphological Categorization by Manual Image Analysis 
Images obtained using INCell Analyzer 2000 were also manually analyzed for 
morphological categorization. As previously, Olig2 staining was used to identify OL and 
GFP signal was used as reporter of infection. α-Tubulin staining was used to visualize 
the cytoskeleton.  
Four morphological stages were established based on the number of primary 
processes, branching degree and cell symmetry (Thurnherr et al., 2006): 
 
 Stage 1: bipolar cell, long unbranched processes; 
 Stage 2: three or more processes, few branches, asymmetrical process 
distribution; 
 Stage 3: five or more processes, symmetrically distributed, few branches, “star-
shaped” cell; 
 Stage 4: five or more processes, symmetrically distributed, highly branched and 
interconnected, “spider-web”-like shaped cell or large, highly ramified “crochet”-
like process network. 
 
Images representative of these morphologies can be seen in Section 3. At least 200 
cells were counted per condition, per experiment with this technique. 
 
 
2.11. Sholl Analysis 
Sholl Analysis plugin in FIJI software was used as following (Ferreira et al., 2014; 
Schindelin et al., 2012): images were thresholded for signal intensity using α-tubulin 
staining (labels all cells) and scale was corrected. Then, Olig2+, GFP+ cells were 
selected and a straight line was traced from the cell body to the end of the longest 
process (without intersecting with neighboring cells). Finally, Sholl Analysis plugin was 
run, with an interval between Sholl Ring radii of 5μm and 3 samples per radius. 
At least 30 cells were analyzed per condition, per experiment with this method. 
 
 
2.12. Statistical Analysis 
Statistical analysis of results was done using Graph Pad Prism 6. Unpaired t-test, one 
sample t-test, one-way ANOVA and two-way ANOVA (with Bonferroni’s multiple 
comparisons test) statistical tests were applied to evaluate significance, as indicated in 
results graphs. 
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3. Results and Discussion 
 
3.1 Development of high-throughput protocols for image 
analysis using INCell Developer Toolbox 
The first aim of this thesis was to develop automated protocols to analyze OL 
morphology and myelin production in a large scale – high-throughput analysis – using 
the INCell Developer Toolbox software. The goal is to quantitatively analyze thousands 
of cells in a short period of time and in an unbiased manner, circumventing qualitative 
and biased analyses like categorization, which rely on users’ opinion and experience in 
recognizing different morphologies. Three different approaches were attempted for OL 
morphological analysis and one for myelin production quantification. 
 
3.1.1. Development of an automated protocol for morphological analysis of OL 
To do a morphological analysis, OL in an immature stage (OL3d), which had been 
previously knocked down with a specific lentiviral-delivered shRNA carrying GFP as a 
reporter gene, were immunostained for α-tubulin and counter-stained with DAPI. Then, 
fluorescence images were acquired using the INCell Analyzer 2000 wide-field 
microscope and analyzed using the INCell Developer Toolbox software.  
First, we analyzed the images in a context module for the analysis of neurite outgrowth, 
already included in the software. We tried to adapt this protocol to oligodendrocytes 
due to morphological similarities with neurons. Briefly, a series of segmentations based 
on fluorescent signal intensity were applied to grey level images, resulting in binary 
images (black pixels – background, white pixels – foreground targets). DAPI signal was 
used to segment nuclei and α-tubulin signal was used to segment cell bodies and 
process networks (Figure 26). Then, images were processed to exclude targets that 
were too big or too small to be real cells and processes. Afterwards, a “clump breaking” 
step was used to separate adjacent cells and targets were linked so that one cell would 
have multiple processes. Finally, mean pixel intensity (density levels) for GFP (reporter 
of infection) was measured for each cell and cells were classified as GFP positive or 
negative based on arbitrary thresholds. The smaller size of OL, their thinner processes 
and the necessity for high confluency in cell culture led to many errors in the automatic 
segmentation (Figure 27). Another challenge encountered during the preparation of 
this protocol was related to fluorescence intensity along processes. The fluorescent 
signal for α-tubulin used in these samples was stronger in the cell body than in the 
processes and much dimmer at the tip of the processes. This required overexposure of 
the cell bodies in order to view the process tips. However, this also increased the 
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background signal, which made it more difficult for the analysis software to distinguish 
background from cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 Image analysis of oligodendrocytes at OL3d. Images represent the result of image analysis using a 
protocol based on a context module for neurite outgrowth. Red arrows indicate the same cells with segmentation errors. 
dsRED-transduced cells stained for α-tubulin. 
Figure 26 Image segmentation. Blue – nuclei (segmented using DAPI signal); Yellow – cell bodies and Green – 
processes (segmented using α-tubulin signal). 
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Due to the high occurrence of segmentation errors and taking into account what we 
had learned while exploring the context module for neurons, we decided to create a 
new protocol. We included an immunostaining against an OL-specific marker, Olig2, to 
exclude the possible analysis of “contaminating cells” such as astrocytes and microglia. 
Olig2 is a transcription factor and localizes preferentially in the nucleus. First, DAPI 
signal was segmented based on signal intensity and eroded to leave a small “seed” 
within the nucleus. This small area within the nucleus was later used to discriminate 
adjacent cells. Then, segmentations were used to identify nuclei (DAPI), cell bodies (α-
tubulin) and processes (α-tubulin). Several intermediate “clump breaking” steps were 
used to separate adjacent cells and to divide processes between them. Finally, cells 
were classified according to their signal intensity as Olig2 and GFP positive or negative. 
The quantitative measurements made included number of processes, process length, 
number of branch points and number of end nodes. At first glance, this protocol 
seemed to work very well but, when cells were very confluent, many processes were 
attributed to one cell only, originating giant cells with huge process networks while 
others would had their processes reduced to 1-2μm long (Figure 28, left). However, 
where cells were less confluent, process segmentation was perfect, indicating that 
further optimization was needed (Figure 28, right). It was expected that, in the overall 
analysis, these segmentation errors would cancel each other out and any differences 
between conditions would be observed. Unfortunately this was not the case (Graph 1). 
The analysis of the number of primary processes, branch points and end nodes did not 
show a significant difference between the control (dsRED shRNA) and the two 
knockdowns, Kank2 and Dusp19. Nevertheless, the data sets represented in red show 
that the knockdown of Kank2 slightly increases the percentage of cells with fewer 
processes, branch points and end nodes, relative to control, indicating a delay in OL 
differentiation. At present time, we were unable to optimize this protocol.  
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Figure 28 Image analysis of oligodendrocytes. Segmentation errors occur frequently when cells are highly confluent 
(left), but not at lower confluency (right). Staining: α-tubulin. 
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Finally, with the collaboration of a GE technical expert, a third protocol was recently 
developed following a different approach. After segmenting nuclei, cell bodies and 
process networks, the area that belonged to the cell body was dilated until a 
neighboring cell was encountered (Figure 29). Instead of outlining whole processes 
from soma to tip, only the processes included inside this large area (the collar, in yellow 
in Figure 29) were counted and measured for length. This prevented process 
overlapping with neighboring cells but did not allow us to measure whole process 
length. Within this area it was possible to quantify total process length within the collar 
and the ratio of process area to total area. Therefore, the greater these measurements, 
the higher the branching and more differentiated the cells were. At present time, this is 
a work in progress and, therefore, we do not have quantitative results to present. 
Overall, the three protocols tested consist in an effort to develop high-throughput image 
analysis methods for morphological studies of OL. These are already in use for 
neuronal cells but have not yet been developed for OL, probably due to technical 
difficulties similar to the ones previously described.  It is an innovative approach that 
we believe will be of great relevance and impact in the field of OL. Therefore, we intend 
to dedicate ourselves to the optimization of at least one of these protocols and apply it 
to future studies as well. 
 
 
 
 
Graph 1 Graphical representations of number of processes, branch points and end nodes of OL at OL3d. 
Results obtained by automated high-throughput analysis using INCell Developer Toolbox. There appears to be an 
increase in the percentage of cells with lower numbers of processes, branch points and end nodes when we knockdown 
Kank2 relative to control. No differences are seen between Dusp19 knockdown and control (n=3). 
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Figure 29 Image analysis of oligodendrocytes. After expanding the cell body until reaching a neighbouring cell it is 
possible to define an area that encases a single OL and its primary processes. Red arrows indicate the same cells in 
both images. dsRED-transduced cells at OL3d, staining α-tubulin. 
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3.1.2. Development of an automated protocol for quantification of myelin 
production 
To quantify OL myelin production, samples of mature OL (OL5d), which had previously 
been transduced with lentiviral-mediated shRNA and GFP reporter, were 
immunostained for MBP and Olig2, and counter-stained with DAPI. The protocol was 
specifically designed to identify MBP positive cells and was the following: 
 
Step 1 – Seed: DAPI signal was segmented based on signal intensity and eroded to 
leave a small “seed” within the nucleus: small area within the nucleus which is later 
used to differentiate between adjacent cells (Figure 30).  
Step 2 – Nuclei: DAPI signal was segmented based on signal intensity. Adjacent cells 
were separated using a “clump breaking” function with seed as secondary target. 
Targets that were too big, too small or that did not meet the requirement for 
approximately circular shape were excluded (Figure 30). 
Step 3 – Measurements: mean pixel intensity within the cells area (density levels) was 
measured for GFP (FITC channel), MBP (Texas Red channel) and Olig2 (Cy5 channel) 
(Figure 31). 
Step 4 – Classifiers: cells were classified as Olig2 positive or negative (Olig2+/Olig2-) 
to exclude contaminating cells such as astrocytes and microglia, GFP positive or 
negative (GFP+/GFP-) to distinguish between transduced and untransduced cells and 
MBP positive or negative (MBP+/MBP-), all based on arbitrary thresholds for density 
levels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30 Segmentation steps used in the automated protocol for analysis of MBP+ cells. Image on the left: 
example of segmentation of seed. Image on the right: example of segmentation of nuclei. Blue – DAPI, yellow – seed, 
red – targets excluded from segmentation.  
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After running the analysis protocol, the results were opened on Spotfire Decision Site 
software to verify if the applied intensity thresholds were appropriate to the sample. For 
example, if a cell appeared to have a high fluorescence intensity of Olig2 staining 
(classified as Olig2+) but its morphology did not resemble that of an oligodendrocyte, 
then it was concluded that the threshold was too low and should be raised in order to 
exclude background or unspecific staining. After identifying the suitable thresholds for 
each channel, the protocol was run again. A table of results was further exported as an 
Excel file containing all fields analyzed, the number of identified targets, the density 
levels measured for each channel for every target and the classification of targets as 
Figure 31 Result of the analysis using the automated protocol for MBP+ cells. Yellow circles outline the nuclei 
segmented using the DAPI signal. Density levels of Cy5 (grey, Olig2), FITC (green, GFP) and Texas Red (red, MBP) 
can then be measured within each circle to determine if cells are Olig2+/-, GFP+/- and MBP+/-. 
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Olig2, GFP and MBP positive or negative. Only Olig2+ targets were considered for 
quantification and, of these, the percentage of GFP+/MBP+ cells was determined. At 
least 1000 cells were analyzed per condition, per experiment using this method. The 
results obtained using this protocol are shown in the next section. 
Overall, this analysis protocol was very successful in discriminating MBP positive from 
MBP negative cells, which is a reliable way to assess the degree of myelin production. 
It is ready to be used in other studies of OL where the percentage of MBP positive cells 
is an important parameter for the characterization of a phenotype. 
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3.2. Functional study of Kank2, Dusp19, PABPC1 and YBX1 in 
OL differentiation and myelination  
An RNASeq analysis of the mRNA pools of OPC processes and soma previously done 
in the laboratory (Domingues, H. S., unpublished data) showed a differential 
expression of many transcripts between the two fractions. Most of the identified 
transcripts were enriched in the OPC processes and many of these were found to be 
related to cytoskeleton rearrangements and protein synthesis. In parallel, an in silico 
analysis searched for RNA binding proteins that could, putatively, interact with the 
3’UTR of markers of OL differentiation and identified some molecules in common with 
the RNASeq (Cruz, A. unpublished data). Of these two data sets, 4 candidates were 
selected for functional validation in OPC/OL differentiation and myelin production: 
Kank2, Dusp19, PABPC1 and YBX1. 
 
3.2.1. Kank2 
Very little is known about the function of Kank2. Its mRNA has been found to be 
enriched in the protrusions of different cell types such as astrocytes processes 
(Thomsen and Nielsen, 2011) and NIH3T3 cells pseudopodia (Mili et al., 2008). Kank1 
is known to inhibit RhoA activation by interaction with 14-3-3 proteins after 
phosphorylation of Kank1 by Akt (Kakinuma et al., 2008). This leads to a decrease in 
actin polymerization and formation of stress fibers. Kank1 also inhibits the formation of 
lamellipodia by preventing the interaction between Rac1 and IRSp53 (Roy et al., 2009). 
Over-expression of all other Kank isoforms (Kank2, Kank3 and Kank4) also inhibits the 
formation of actin stress fibers in NIH3T3 cells (Zhu et al., 2008). Very recently, Kank2 
was identified as an interactor of RhoGDI in podocytes, enhancing RhoGDI-mediated 
inhibition of RhoA (Gee et al., 2015). When Kank2 is knocked-down, levels of active 
RhoA rise, possibly due to a lower interaction with RhoGDI. In OL, RhoA is an inhibitor 
of process extension and branching. When RhoA (Liang et al., 2004) or its effector 
kinase ROCK (O'Meara et al., 2013) is inhibited, OL become more differentiated. With 
this in mind, we hypothesize that Kank2 may be a regulator of RhoA in OL. 
We have previously observed that Kank2 mRNA expression increases during in vitro 
OL differentiation and is enriched in the OPC processes. Moreover, Kank2 protein is 
found in CNS white matter regions such as optic nerve, cerebellum and spinal cord and 
it co-localizes with α-tubulin but not actin in all stages of OL differentiation in vitro 
(Domingues, H.S., unpublished data, not shown). 
Next, to address the functional role of Kank2 in OL differentiation and myelination, a 
shRNA was designed and cloned into a lentiviral plasmid to deplete the mRNA 
expression. The knockdown efficiency of this shRNA was evaluated by quantitative real 
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time PCR at OL0d, 2 days post-infection (dpi). It was found that the shRNA for Kank2 
had a knockdown efficiency of 60% (Graph 2). However, taking into account the fact 
that the infection efficiency was never 100% but mostly between 40-50%, we predict an 
effective higher efficiency of this shRNA per infected cell.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to assess the effect of Kank2 knockdown in OL process extension and 
branching, we immunostained samples of OL3d (5 dpi) against the OL lineage-specific 
marker Olig2 and α-tubulin, and counter-stained with DAPI. GFP was used as a 
reporter of infection (dsRED shRNA or Kank2 shRNA). Fluorescence images were 
obtained using the INCell Analyzer 2000 microscope and manually analyzed by 
morphological categorization, as previously described by Thurnherr et al. (2006). Four 
stages of classification were established based on number of processes, degree of 
branching and cell symmetry (Figure 32). 
 
 
 
 
 
 
 
 
 
 
Graph 2 Knockdown efficiency of Kank2 shRNA. qPCR shows a reduction of Kank2 mRNA levels of 60% relative to 
GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL0d. N=5, bars represent mean plus 
SEM, one sample t-test, P<0.001(***). 
        Stage 1                       Stage 2                     Stage 3                    Stage 4 
Figure 32 Morphological categorization of OL development. OL morphology was classified in four stages of 
increasing complexity. Staining: α-tubulin. Scale bar: 20μm. 
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Manual analysis by morphological categorization showed a delay in OL process 
extension and branching at OL3d (5 dpi) when Kank2 is knocked-down by shRNA, 
relative to control (Figure 33, Graph 3). Although we only achieved statistical 
significance for stage 3, it can be observed an increased percentage of mutant cells in 
stages 1 and 2 and a reduction of the percentage of cells in stage 4, when compared 
with the control dsRED. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 3 Distribution of Olig2+GFP+ cells in four morphological stages. Knockdown of Kank2 delays OL 
differentiation: cells accumulate in stages 1 and 2, leading to a reduction in the percentage of cells in stages 3 and 4 at 
OL3d, relative to control. N=3, bars represent mean plus SEM, two-way ANOVA, P<0.05 (*). 
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Figure 33 Representative picture of control and Kank2 knockdown cells at OL3d. Knockdown of Kank2 leads to 
less differentiated cells, relative to control. Green: GFP (reporter of infection), blue: Olig2 (marker for OL), red: α-tubulin. 
Scale bar: 30μm. 
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Afterwards, we performed immunostaining on samples of OL5d (7 dpi) to visualize 
myelin production. Cells were stained for Olig2 and MBP, and counter-stained with 
DAPI. GFP was used as a reporter of infection (dsRED shRNA or Kank2 shRNA). 
Fluorescence images were obtained using the INCell Analyzer 2000 microscope and 
analyzed using the automated protocol we developed with INCell Developer Toolbox 
software. We determined the percentage of MBP+ cells and we observed that knocking 
down Kank2 significantly reduced the percentage of MBP+ cells at OL5d (7dpi), relative 
to control (Figure 34, Graph 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34 Representative picture of control and Kank2 knockdown cells at OL5d. Knockdown of Kank2 leads to 
less MBP+ cells, relative to control. Green: GFP (reporter of infection), blue: Olig2 (marker for OL), red: MBP. Scale bar: 
30μm. 
Graph 4 MBP production of control and Kank2 knockdown cells. Knockdown of Kank2 significantly impairs the 
percentage of MBP+ cells at OL5d, relative to control. N=5, bars represent mean plus SEM, unpaired t-test, P<0.05 (*). 
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To verify if this reduction in MBP production was occurring also at mRNA level, we 
performed qPCR of OL at OL5d. This analysis showed, however, a non-significant 
reduction in the levels of MBP mRNA (Graph 5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These results suggest that knockdown of Kank2 delays OL differentiation and may 
inhibit the production of markers of myelination, in this case MBP. We hypothesize that 
Kank2 may play these roles through the modulation of RhoA signaling. If Kank2 is an 
interactor of RhoGDI in OL as in other models, the lack of Kank2 may lead to a down-
regulation of RhoGDI and an up-regulation of RhoA, causing a delay in OL 
differentiation (Gee et al., 2015; Liang et al., 2004). To better understand the role of 
Kank2 in OL process extension, its relationship with RhoA must be addressed. By 
pulldown assay, we will soon investigate if the depletion of Kank2 causes any changes 
in the levels of active RhoA. If the pathway is conserved in OL as it has been described 
in NIH3T3 cells and podocytes(Gee et al., 2015; Zhu et al., 2008), then we expect to 
observe an activation of RhoA when Kank2 is depleted. Moreover, it would also be 
interesting to analyze the expression of other Kank isoforms (Kank1, Kank3 and 
Kank4) during OL differentiation and address if these are modulated in Kank2-depleted 
OL. Finally, R. Kyiama and co-workers have suggested that Kank isoforms may share 
similar functions after observing that over expression of all four Kanks had similar effect 
in stress fiber formation in NIH3T3 cells (Kakinuma et al., 2008; Zhu et al., 2008). 
These authors have recently provided us these constructs for all Kank isoforms and it 
will be interesting to address in the future if the different Kank isoforms play similar 
roles in OL process extension.  
  
Graph 5 Knockdown of Kank2 leads to a reduction of MBP mRNA levels. qPCR shows a reduction of MBP mRNA 
relative to GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL5d. N=3, bars represent 
mean plus SEM, one sample t-test, ns – not significant. 
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3.2.2. Dusp19 
Dusp19 is a serine/threonine and tyrosine phosphatase involved in the regulation of 
ASK1/MKK7/JNK signaling (Zama et al., 2002b). However, it is not clear whether the 
function of Dusp19 in this pathway is as a phosphatase or as a scaffold protein (Zama 
et al., 2002a; Zama et al., 2002b). In OL, JNK/c-Jun signaling pathway is a known 
regulator of MBP production (Parkinson et al., 2008) and in neurons JNK/MAP1B 
signaling pathway is important for microtubule bundling and neurite elongation (Feltrin 
et al., 2012). This suggests a possible role of Dusp19 in OL process extension and 
myelination.  
It has been previously observed that Dusp19 mRNA expression increases during in 
vitro OL differentiation and is enriched in the OPC processes. Also, Dusp19 protein is 
found in CNS white matter regions such as optic nerve, cerebellum and spinal cord and 
co-localizes with α-tubulin but not actin in all stages of OL differentiation in vitro 
(Domingues, H.S., unpublished data, not shown) 
To evaluate the functional role of Dusp19 in OL differentiation and myelination, as done 
for Kank2, a shRNA was previously designed and cloned into a lentiviral plasmid to 
deplete the mRNA expression. It was found by qPCR that the shRNA for Dusp19 had a 
knockdown efficiency of 66% at OL0d (2dpi) (Graph 6). As described for Kank2, the 
efficiency of Dusp19 shRNA per infected cell is expected to be higher.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to assess the effect of Dusp19 knockdown in OL process extension and 
branching, we performed immunocytochemistry on samples at OL3d (5 dpi). As 
described for Kank2, cells were immunostained against Olig2 and α-tubulin, and 
counter-stained with DAPI (Figure 32). Categorization analysis showed a delay in OL 
Graph 6 Knockdown efficiency of Dusp19 shRNA. qPCR shows a reduction of Dusp19 mRNA levels of 66% relative 
to GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL0d. N=4, bars represent mean plus 
SEM, one sample t-test, P<0.0001(****). 
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differentiation when Dusp19 is knocked down by shRNA (Figure 35, Graph 7). 
Similarly to Kank2 knockdown, we only achieved statistical significance for stage 3, but 
it can be observed there is an increase of the percentage of mutant cells in stages 1 
and 2 and a reduction of the percentage of cells in stage 4, when compared with 
dsRED control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35 Representative picture of control and Dusp19 knockdown cells at OL3d. Knockdown of Dusp19 leads to 
less differentiated cells, relative to control. Green: GFP (reporter of infection), blue: Olig2 (marker for OL), red: α-tubulin. 
Scale bar: 30μm. 
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          dsRED shRNA                      Dusp19 shRNA 
Graph 7 Distribution of Olig2+GFP+ cells in four morphological stages. Knockdown of Dusp19 delays OL 
differentiation: cells accumulate in stages 1 and 2, leading to a reduction in the percentage of cells in stages 3 and 4 at 
OL3d, relative to control. N=3, bars represent mean plus SEM, two-way ANOVA, P<0.05 (*). 
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Afterwards, we analyzed samples of OL5d (7 dpi) to quantify the percentage of infected 
OL producing myelin. Likewise, cells were immunostained against Olig2 and MBP, and 
counter-stained with DAPI. Interestingly. the quantification of infected MBP+ OL using 
the automated analysis protocol we developed (described in section 3.1) showed the 
absence of Dusp19 significantly decreased the percentage of MBP+ cells at OL5d, 
relative to the control (Figure 36, Graph 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36 Representative picture of control and Dusp19 knockdown cells at OL5d. Knockdown of Dusp19 leads to 
less MBP+ cells, relative to control. Green: GFP (reporter of infection), blue: Olig2 (marker for OL), red: MBP. Scale bar: 
30μm. 
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              dsRED shRNA                             Dusp19 shRNA 
Graph 8 MBP production of control and Dusp19 knockdown cells. Knockdown of Dusp19 significantly impairs the 
percentage of MBP+ cells at OL5d, relative to control. N=5, bars represent mean plus SEM, unpaired t-test, P<0.05 (*). 
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We also analyzed the expression of MBP by qPCR and observed a significant 
reduction in the levels of MBP mRNA (Graph 9) in the absence of Dusp19, showing a 
positive correlation between the mRNA and protein levels of MBP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These results suggest that, by knocking down Dusp19, OL differentiation is delayed. 
We hypothesize that this may be due to an inhibition of ASK1/MKK7/JNK signaling 
complex assembly or to a direct dephosphorylation of MKK7 by Dusp19. This may lead 
to a down-regulation of JNK phosphorylation and, consequently, dephosphorylation of 
MAP1B and disassembly of microtubule bundles inside OL processes as described in 
neurons (Feltrin et al., 2012). Depletion of Dusp19 also led to a decrease in the 
percentage of MBP+ cells and in MBP mRNA levels, relative to control. We have not 
seen any differences in the levels of phospho-c-Jun in control and Dusp19-depleted OL 
(Western Blotting, data not shown). It is possible that during OL process extension, 
Dusp19 works as a scaffold protein and not as a phosphatase. Therefore, knocking 
down Dusp19 may be affecting the MKK7-JNK-MAP1B pathway without affecting 
directly myelination through the JNK-c-Jun interaction. Additionally, it is known that OL 
differentiation is a two-step inter-dependent process: first, processes are extended and 
ramified and, later, production of myelin components is initiated. Therefore, the 
inhibition of process extension through the MKK7-JNK-MAP1B pathway by the 
depletion of Dusp19 may consequently compromise the necessary signals to induce 
MBP synthesis. This would justify why we observe less myelinated OL when Dusp19 is 
depleted. To understand if and how Dusp19 knockdown affects the JNK pathway, 
protein levels and phosphorylation state of JNK pathway molecules, such as MKK7, 
Graph 9 Knockdown of Dusp19 leads to a reduction of MBP mRNA levels. qPCR shows a reduction of MBP mRNA 
relative to GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL5d. N=3, bars represent 
mean plus SEM, one sample t-test, P < 0.01 (**). 
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JNK and MAP1B will, in the near future, be quantified in control and Dusp19 
knockdown cells by Western Blotting. 
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3.2.3. Sholl Analysis of Kank2 and Dusp19 knockdown 
In order to get a quantitative measure of the degree of OL differentiation, the Sholl 
analysis technique was applied to the images previously analyzed by morphological 
categorization. This analysis was applied only to cells that were Olig2+, GFP+ and 
representative of the morphologies previously observed. After thresholding images for 
signal intensity using α-tubulin staining and correcting the scale, Olig2+/GFP+ cells 
were selected and a straight line was traced from the cell body to the extremity of the 
longest process (without intersecting with neighboring cells). Finally, Sholl Analysis 
plugin was run, with step size between Sholl Ring radii of 5μm and 3 samples per 
radius. This analysis showed a significant reduction in the number of intersections 
between processes and a Sholl ring at a distance of 20μm from the cell body when 
cells were depleted of Kank2. This means that Kank2-depleted cells are less 
differentiated than control cells. Nevertheless, no differences were observed between 
control and Dusp19-depleted cells at all distances considered. One of the reasons that 
may have contributed to these results is the high variability observed in Sholl profiles of 
control cells (Graph 10). This is probably due to the high confluency of these cultures, 
which made it difficult to find cells that were infected and sufficiently isolated, so that 
the Sholl rings would not intersect processes of neighboring cells. Because of that, only 
30 cells were analyzed per condition per experiment. If we had analyzed a greater 
number of cells per experiment, we might have reduced the error. Since OL 
differentiate better in vitro when in close proximity, it is possible that the cells selected 
for Sholl analysis were less differentiated because of the greater distance between 
them and their neighbors. 
 
 
 
 
 
 
 
 
 
 
  
Graph 10 Sholl Analysis of OL at OL3d. Graphical representation of the mean number of intersections as a function of 
Sholl Ring radius. For the control, as Sholl Ring radius increases, the number of intersections peaks indicating an 
increase in the number of processes and branches, and then decreases because there are fewer cells with longer 
processes. A lower number of intersections for Kank2 and Dusp19 knock-down indicates these cells are less 
differentiated. At 20μm in radius, Kank2 knock-down is significantly different from control. N=3, points represent mean 
plus SEM, two-way ANOVA, Bonferroni’s test P<0.05 (*). 
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3.2.4. PABPC1 
PABPC1 is an RNA-binding protein necessary for RNA stability, transport and 
translation, through binding to PolyA tails. It may also bind regulatory regions in the 
3’UTR of many mRNAs, including markers of OL differentiation such as MBP (in silico 
analysis, Cruz, A., unpublished data). In HeLa cells, depletion of PABPC1 impaired 
mRNA translation, but not transcription, and led to apoptosis (Zannat et al., 2011). 
Over-expression of PABPC1 caused a decrease in mRNA levels of several genes due 
to changes in mRNA stability (Ma et al., 2006). This induced a feedback mechanism 
led by PABPC1 binding to a regulatory region in the 3’UTR of MKK2 mRNA, which 
destabilized it leading to a decrease in MKK2 mRNA and protein levels. Reduced 
levels of MKK2 inhibited the phosphorylation of PABPC1, preventing it from binding to 
mRNAs and causing more adverse effects.  
PABPC1 mRNA is significantly enriched in OPC processes and its expression levels 
decrease during OL differentiation in vitro. At the protein level, PABPC1 can be seen in 
the brain and in cultured OL in vitro by immunohistochemistry (Domingues, H.S. and 
Cruz, A., unpublished data, not shown). 
As previously described, to study the functional role of PABPC1 in OL differentiation 
and myelination, a shRNA was designed and cloned into a lentiviral plasmid to deplete 
the mRNA expression. By qPCR, it was found that the shRNA for PABPC1 had a 
knockdown efficiency of 80% at OL3d (3 dpi) (Graph 11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 11 Knockdown efficiency of PABPC1 shRNA. qPCR shows a reduction of PABPC1 mRNA levels of 80% 
relative to GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL5d. N=4, bars represent 
mean plus SEM, one sample t-test, P<0.001(***). 
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Again, to evaluate the effect of PABPC1 knockdown in OL process extension and 
branching, we performed immunocytochemistry of samples of OL3d (3 dpi).as 
described for Kank2 and Dusp19 (Figure 32). Manual analysis shows a delay in OL 
process extension and ramification at OL3d when PABPC1 is knocked-down by 
shRNA, relative to control. (Figure 37, Graph 12). In this condition, there is a 
significant difference in the percentage of cells in stage 2 for the knockdown relative to 
control. Although not statistically significant, it can be observed there is a decrease of 
the percentage of cells in stages 3 and 4, relative to the control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 12 Distribution of Olig2+GFP+ cells in four morphological stages. Knockdown of PABPC1 delays OL 
differentiation: cells accumulate in stage 2, leading to a reduction in the percentage of cells in stages 3 and 4 at OL3d, 
relative to control. N=5, bars represent mean plus SEM, two-way ANOVA, Bonferroni’s test, P<0.01 (**). 
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Figure 37 Representative picture of control and PABPC1 knockdown cells at OL3d. Knockdown of PABPC1 leads 
to less differentiated cells, relative to control. Green: GFP (reporter of infection), blue: Olig2 (marker for OL), red: α-
tubulin. Scale bar: 30μm. 
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Next, we performed immunostaining of samples of OL5d (5 dpi) to quantify the 
production of myelin, as done for Kank2 and Dusp19. Similarly, automated analysis of 
MBP+ cells using the automated protocol showed that knockdown of PABPC1 impairs 
MBP production at OL5d (Figure 38, Graph 13). Interestingly, due to the high 
variability between experiments, this difference is not statistically significant if results 
are expressed in percentage. However, if they are expressed in fold change relative to 
control, it becomes highly significant (P<0.01). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Graph 13 MBP production of control and PABPC1 knockdown cells. Knockdown of PABPC1 significantly impairs 
the percentage of MBP+ cells at OL5d, if results are expressed as fold change relative to control. N=5, bars represent 
mean plus SEM, unpaired t-test, ns – not significant (left graph) and one sample t-test, P<0.01 (**) (right graph). 
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Figure 38 Representative picture of control and PABPC1 knockdown cells at OL5d. Knockdown of PABPC1 leads to 
less MBP+ cells when compared to control. Green: GFP (reporter of infection), blue: Olig2 (marker for OL), red: MBP. 
Scale bar: 30μm. 
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To confirm the decrease in MBP+ cells by immunocytochemistry, qPCR for MBP was 
performed. This analysis showed a significant reduction in the levels of MBP mRNA 
(Graph 14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
These results indicate that PABPC1 may act as a promoter of both process extension 
and myelination in in vitro cultured OL. However, we do not know if this is due to the 
role of PABPC1 as a PolyA-binding protein or as a trans-acting regulator of mRNA 
stability and translation through 3’UTR sequences. 
Further investigation is needed to understand the mechanism by which PABPC1 
depletion impairs OL process extension and myelination: it may be due to a general 
impairment of protein synthesis or a specific regulation of cytoskeleton and myelin 
genes. The PBS Finder software developed by A. Cruz could be used to identify 
putative binding sites of PABPC1 to mRNAs of cytoskeleton-related genes, such as 
integrins, Rho GTPases and molecules in MAPK signaling pathway. 
 
  
Graph 14 Knockdown of PABPC1 leads to a reduction of MBP mRNA levels. qPCR shows a reduction of MBP 
mRNA relative to GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL5d. N=3, bars 
represent mean plus SEM, one sample t-test, P < 0.05 (*). 
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3.2.5. YBX1  
YBX1 is an RBP involved in processes such as DNA replication, transcription and 
translation. In the cytoplasm, it can act as a packaging protein of RNPs (Minich and 
Ovchinnikov, 1992) and it regulates translation in a dose-dependent manner, inhibiting 
translation at high YBX1-mRNA ratios and promoting it at low ratios by unfolding RNPs 
(Skabkin et al., 2004) In OL, YBX1 binds directly to MBP mRNA (RNA 
immunoprecipitation assay, Cruz, A., unpublished data, not shown) and may bind to 
other markers of OL differentiation (in silico analysis, Cruz, A., unpublished data, not 
shown). 
YBX1 mRNA expression levels peak at OL3d stage of OL differentiation in vitro. At the 
protein level, YBX1 can be seen in the brain and in cultured OL in vitro (Domingues, 
H.S. and Cruz, A., unpublished data, not shown). 
As before, to assess the functional role of PABPC1 in OL differentiation and 
myelination, a shRNA was designed and cloned into a lentiviral plasmid to deplete the 
mRNA expression By qPCR, it was found that the shRNA for YBX1 had a knockdown 
efficiency of 56% at OL3d (3 dpi) (Graph 15).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Again, to evaluate the effect of PABPC1 knockdown in OL process extension and 
branching, we performed immunostaining on samples of OL3d (3 dpi) as previously 
described (Figure 32). Morphological categorization shows a delay in OL differentiation 
when YBX1 is knocked-down by shRNA at OL3d (Figure 39, Graph 16). In this 
condition, there is a statistically significant increase in the percentage of cells in stage 2 
Graph 15 Knockdown efficiency of YBX1 shRNA. qPCR shows a reduction of YBX1 mRNA levels of 56% relative to 
GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL5d). N=3, bars represent mean plus 
SEM, one sample t-test, P<0.05(*). 
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and a reduction in the percentage of cells in stage 3, relative to control. Despite the 
lack of statistical significance, an increase in the percentage of cells in stage 1 and a 
reduction in stage 4 can be observed as well. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Graph 16 Distribution of Olig2
+GFP+ cells in four morphological stages. Knockdown of YBX1 delays OL 
differentiation: cells accumulate significantly in stage 2, leading to a significant reduction in the percentage of cells in 
stages 3 at OL3d, relative to control. N=3, bars represent mean plus SEM, two-way ANOVA, Bonferroni’s test, P<0.05 
(*). 
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Figure 39 Representative picture of control and YBX1 knockdown cells at OL3d. Knockdown of YBX1 leads to less 
differentiated cells relative to control. Green: GFP (reporter of infection), blue: Olig2 (marker for OL), red: α-tubulin. Scale 
bar: 30μm. 
FCUP 
The Oligodendrocyte “processosome”: novel regulators of differentiation and myelination 
81 
 
Then, we performed ICC on samples of OL5d (5 dpi) to visualize the production of 
myelin, as previously. Automated analysis of MBP+ cells using the INCell Developer 
Toolbox showed a non-significant increase in the percentage of MBP+ cells at OL5d 
when YBX1 is knocked-down, relative to control (Figure 40, Graph 17).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Graph 17 MBP production of control and YBX1 knockdown cells. Knockdown of YBX1 causes a non-significant 
increase in the percentage of MBP+ cells at OL5d. N=3, bars represent mean plus SEM, unpaired t-test (left graph) and 
one sample t-test (right graph), ns – not significant. 
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Figure 40 Representative picture of control and YBX1 knockdown cells at OL5d. Knockdown of YBX1 does not 
alter the percentage of MBP+ cells when compared to control. Green: GFP (reporter of infection), blue: Olig2 (marker for 
OL), red: MBP. Scale bar: 30μm. 
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qPCR for MBP was performed to verify the previous result. This showed an increase in 
the levels of MBP mRNA (Graph 18). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Knockdown of YBX1 has a clear effect in the delay of OL process extension and 
branching, as shown by the statistically significant increase of the percentage of cells in 
morphological stage 2 and decrease of the percentage of cells in stage 3. To 
understand the role of YBX1 in OL process extension we should look for interactions 
between YBX1 and regulators of cytoskeleton dynamics. Again, the PBS Finder may 
be a useful tool for the identification of putative candidates for functional studies.  
Relatively to MBP, the knockdown of YBX1 presents a very interesting result that 
suggests a decoupling between process extension and myelin production. The 
increase in mRNA levels is accompanied by a non-significant increase in the 
percentage of MBP+ cells. Despite being transcribed at early stages of OL 
development, MBP is only translated later on (Laursen et al., 2011). YBX1 binding to 
MBP mRNA may be necessary to maintain it silenced until the cell receives the 
appropriate stimulus to initiate translation. By depleting YBX1, we may have promoted 
MBP translation at an earlier time point, which is why YBX1 knockdown cells have a 
slightly greater percentage of MBP positive staining than control cells at OL5d. This 
change in MBP mRNA turnover may also be responsible for the increase in mRNA 
levels observed. To shed light on this possibility, we are working on determining the 
percentage of MBP+ cells at OL3d. This will tell us if MBP production is being 
anticipated in YBX1-depleted cells, relative to control.  
  
Graph 18 Knockdown of YBX1 leads to an increase of MBP mRNA levels. qPCR shows an increase of MBP mRNA 
relative to GAPDH (reference gene) and to control cells infected with dsRED shRNA, at OL5d. N=3, bars represent 
mean plus SEM, one sample t-test, P < 0.05 (*). 
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4. Conclusions 
The main function of oligodendrocytes is to establish and maintain myelin sheaths 
around axons. To do so, they must extend cytoplasmic processes, alter their shape to 
enwrap an axon and produce proteins essential for myelin compaction. These 
processes demand great cytoskeletal changes and timed protein synthesis in order to 
ensure efficient myelination. 
In this Master thesis, we aimed to characterize the function of four proteins in OL 
differentiation and myelination in vitro. Kank2 and Dusp19 are two novel identified 
regulators of OL differentiation. These were previously identified in an RNAseq screen 
that compared mRNA fractions obtained from the soma and processes of OPC, being 
enriched in the OPC processes (Domingues, H.S., unpublished data). PABPC1 and 
YBX1 are two known RNA-binding proteins and were also identified to be enriched in 
the OPC processes. PABPC1 appears to bind to 3’UTR of mRNAs of all known OL 
differentiation markers, such as NG2, Olig1 and 2, PDGFRα, CNP, MBP, MOBP, MOG, 
MAG and PLP1, whereas YBX1 appears to bind mostly to earlier ones, such as Olig1 
and 2, PDGFRα and CNP, but it may also bind to the late markers MBP and MOBP 
(Cruz, A., unpublished data). 
Our approach to address the function of these proteins in OL differentiation was to 
deplete their mRNA expression via lentivirus-mediated shRNA delivery. We validated 
the knockdown efficiency of these shRNAs by qPCR and studied their effect in OL 
process extension and ramification, as well as production of MBP, by fluorescence 
microscopy and qPCR. 
We found that knockdown of Kank2, Dusp19 and PABPC1 impaired both OL process 
extension (cells accumulated in earlier morphological stages and did not progress to 
later stages, when compared to control) and myelin production (the percentage of 
MBP+ cells was significantly reduced when compared to control).  
Kank2 is an inhibitor of RhoA in podocytes, through interaction with RhoGDI (Gee et 
al., 2015). When Kank2 is knocked down, levels of active RhoA rise and when it is 
over-expressed in NIH3T3 cells they decrease, which is accompanied by a reduction in 
the formation of actin stress fibers (Zhu et al., 2008). In OL, RhoA is an inhibitor of 
process extension and branching: when RhoA (Liang et al., 2004) or ROCK (O'Meara 
et al., 2013) is inhibited, OL become more differentiated. In our experiments, 
knockdown of Kank2 led to a delayed morphological differentiation of OL and to lower 
levels of MBP production, consistent with the putative role of Kank2 as an inhibitor of 
RhoA. 
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Dusp19 is a serine/threonine and tyrosine phosphatase involved in the regulation of 
ASK1/MKK7/JNK signaling (Zama et al., 2002b). Knockdown of Dusp19 may impair 
JNK-MAP1B signaling, which could inhibit OL process extension (given its role in 
neurite elongation (Feltrin et al., 2012)), consistent with our observations. Given the 
role of c-Jun as an inhibitor of MBP transcription, Dusp19 knockdown could inactivate 
c-Jun and cause an increase in MBP mRNA levels, which we did not observe. On the 
other hand, the delay in process extension could compromise the reception of MBP 
production-inducing signals by the cell, without interfering with c-Jun. Therefore, other 
molecules must be at play, which requires further investigation. 
PABPC1 is an RNA-binding protein necessary for the regulation of mRNA translation 
(Kahvejian et al., 2005) and degradation (Ford et al., 1997). Given its ubiquitous role in 
binding the polyA tails of mRNAs and its putative binding to the 3’UTR of OL markers 
of differentiation and myelin genes, its knockdown should impair many cellular 
functions. In fact, we observed a delay in OL process extension and MBP expression, 
which means PABPC1 may be an essential promoter of both processes. 
On the other hand, knockdown of YBX1 delayed process extension but increased MBP 
levels, suggesting a decoupling of the two mechanisms. YBX1 is an RBP that can act 
as a packaging protein of RNPs (Minich and Ovchinnikov, 1992) regulating translation 
in a dose-dependent manner, either inhibiting or promoting it depending on the YBX1-
mRNA ratio (Skabkin et al., 2004) In OL, it binds directly to MBP mRNA (RNA 
immunoprecipitation assay, Cruz, A., unpublished data, not shown) and may bind to 
other markers of OL differentiation (in silico analysis, Cruz, A., unpublished data, not 
shown). Regarding MBP production, there was a non-significant increase in the 
percentage of MBP+ cells at OL5d and mRNA levels of MBP were higher than those of 
control cells. Despite being transcribed at early stages of OL development, MBP is not 
translated until a later stage is reached (Laursen et al., 2011). Binding of YBX1 to MBP 
mRNA could be a silencing mechanism to prevent MBP production until the cell 
receives an appropriate stimulus. By depleting OL of YBX1, we may have induced 
MBP translation at an earlier time point, which is why YBX1 knockdown cells have a 
slightly greater percentage of MBP positive staining compared to control at OL5d. This 
alteration in the rate of MBP translation may also be accompanied by changes in 
transcription and/or degradation, which may be responsible for the increase in mRNA 
levels observed. 
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5. Future perspectives 
The next steps in this project are the dissection of signaling pathway mechanisms 
involving Kank2, Dusp19, PABPC1 and YBX1, and to continue the improvement of the 
automated high-throughput analysis protocol. 
We are currently working with CG4 (a rat oligodendrocyte cell line) and NIH3T3 cells (a 
mouse fibroblast cell line) to perform biochemical analysis of RhoA activity by pulldown 
in control and Kank2 knockdown cells. This will allow us to see if there are any 
alterations in RhoA levels and activity. We are also going to look at the expression of 
other Kank family members (Kank1, 3 and 4) in control and Kank2 knockdown cells to 
see if there is any compensatory or synergistic effect with Kank2 in OL differentiation. 
We are also going to evaluate the effect of over-expressing the different Kank isoforms 
(plasmids were a courtesy of Dr. Ryoiti Kiyama, Japan). 
Regarding Dusp19, we are focusing on the JNK pathway by looking at JNK protein 
levels and phosphorylation state in control and Dusp19 knockdown cells. We will also 
look at the levels other JNK pathway molecules like MKK7 and MAP1B, total and 
phosphorylated forms. In collaboration with Dr. Fatiha Nothias (France), we will analyze 
the role of Dusp19 in MAP1B phosphorylation through JNK (Barnat et al., 2010).  
In what respects the RNA-binding proteins, PABPC1 and YBX1, we will look at their 
relationship after knockdown (collaboration with Dr. Andrea Cruz). We hypothesize 
they regulate each other during OL development. We are also investigating whether 
MBP production in YBX1 knockdown cells is increased at an earlier time point, OL3d. 
Our preliminary data suggest that there is, in fact, a higher percentage of MBP+ cells at 
OL3d after YBX1 knockdown, relative to control (19% vs. 5%, data not shown), but we 
still need to confirm by increasing the number of experiments. Finally, we could do an 
in silico analysis to look for putative binding sites in the 3’UTR of cytoskeleton and 
myelin-related genes, such as molecules involved in RhoA, integrin and MAPK 
signaling pathways. 
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6. Challenges 
The main challenge encountered in this project was the high variability among 
experiments. This is due to several factors: first, we were working with primary mixed 
glial cell cultures from wild-type Wistar rats. Each of these cultures were prepared from 
brain cortices of at least 10 individuals, a minimum of three independent OPC/OL 
cultures was done. Second, we used lentivirus as a vector for shRNA delivery, because 
OL are cells very difficult to transfect. Although viral preparations were titrated to 
estimate the number of transducing units per microliter and a multiplicity of infection of 
1:1 was used, efficiency of infection was variable and relatively low – 50% or less in 
some cases. In addition, cells were classified as infected when exhibiting green 
fluorescence, due to the expression of GFP included in the plasmid. It should be noted 
that GFP and the shRNA were expressed under different promoters, so a higher 
intensity of fluorescence does not necessarily correlate with a higher knockdown effect, 
and vice-versa. We may have overlooked many cells that were effectively undergoing 
mRNA knockdown but did not reach the arbitrary fluorescence threshold applied. 
Thirdly, it is not possible to obtain pure differentiation stages in OL primary cultures, but 
only enriched populations. Though OPC were initially cultured in a proliferative medium 
and then switched to a differentiation medium, differentiation was not completely 
synchronous among all cells. This means that some cells would differentiate faster than 
others, despite being cultured in the same conditions. Another difficulty was related to 
cell confluency: OPC were plated on laminin-2-coated surfaces, which cannot dry 
otherwise it will become inactive, but it cannot be too wet because the cell suspension 
would spread too much and cells would be plated farther apart. It was challenging to 
achieve a consistent technique that would result in cultures with similar confluencies 
throughout experiments. OL differentiate better when they are in closer physical 
proximity thanks to chemotactic cues; however it is difficult to visualize cellular 
morphology in these conditions. High cell confluency is the main reason why it was so 
difficult to perform Sholl Analysis and to optimize the automated high-throughput 
analysis protocol for process extension. Finally, and as previously mentioned, OL have 
very thin processes which makes them difficult to visualize by wide-field fluorescence 
microscopy. Staining with anti-α-tubulin antibodies was irregular and faint at the tips of 
OL processes, even when the sample was overexposed. However, overexposure had 
as a consequence an increase in background noise, which made it difficult to identify 
processes using the automated protocol. 
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As a final commentary, I would like to say that I found the technical demands of this 
project to be good for my training as a scientist. I learned to solve problems and fine-
tune procedures and techniques, which I think are essential skills for a good scientist.  
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